rfhg_140161.1

Basic information about the TSS

---

TSS ID: rfhg_140161.1 TSS ID(Version3): hg_120945.1 Species: human Chr: chr11		Start: 67507779 End: 67507835 Strand: -
Source datasets	FANTOM5|PRJDB5282
Protocol	CAGE|C1CAGE
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000526447.1:-241 GeneID: 10263 HGNC/MGI_ID: HGNC:30833 UniProt_ID: Nearer transcript ids and distances: CR457050:-247 BT006909:-247 CR542042:-247 KJ892981:-253 ENST00000531506.1:-256 ENST00000531178.1:-323 AK310197:-323 ENST00000301488.8:-327 NM_001271849.2:-327 NM_005851.5:-327 NR_073484.2:-327 AK001498:-327 BC016704:-327 AF089814:-350 view more...

Gene_name: cyclin dependent kinase 2 associated protein 2 Gene_symbol: CDK2AP2 Gene_synonyms: DOC-1R p14 Gene_source: HGNC:30833

TATA-Box annotation

---

Distance to TSS:	355
Nearest PromoterID:	NM_001271849
Entrez ID:	10263
Nearest Unigene:	Hs.523835
Nearest Refseq:	NM_005851
Nearest Ensembl:	ENSG00000167797
Gene Name:	cyclin dependent kinase 2 associated protein 2
Gene Alias:	DOC-1R|p14
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.508772
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CDK2AP2 p2@CDK2AP2 p3@CDK2AP2 p4@CDK2AP2 p5@CDK2AP2 p6@CDK2AP2 p7@CDK2AP2 p8@CDK2AP2 p9@CDK2AP2
Sample		p1@CDK2AP2	p2@CDK2AP2	p3@CDK2AP2	p4@CDK2AP2	p5@CDK2AP2	p6@CDK2AP2	p7@CDK2AP2	p8@CDK2AP2	p9@CDK2AP2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	27.47	4.87	1.95	1.56	0.58	1.36	0.00	0.39	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	23.47	7.69	1.21	1.62	1.01	3.03	0.20	0.40	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	25.85	7.72	0.58	2.12	1.16	2.70	0.00	0.58	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	25.37	7.28	1.66	0.62	0.62	1.46	0.62	0.42	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	30.15	7.87	0.90	1.35	0.90	1.12	0.00	1.57	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	26.16	10.08	1.74	1.36	1.16	2.13	0.58	1.16	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	35.51	8.28	2.18	0.65	0.44	1.31	0.22	0.65	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	42.39	5.81	3.15	0.97	0.73	1.45	0.24	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	35.05	8.55	1.92	2.78	0.85	2.56	0.21	0.21	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	66.66	9.85	1.74	0.58	0.00	1.16	0.58	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	61.04	15.36	2.02	1.21	0.00	2.02	0.00	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	63.02	15.04	2.03	1.22	0.81	0.81	0.41	1.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	10.32	3.55	2.26	1.13	1.77	2.74	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	9.92	2.71	3.91	1.35	0.30	1.95	0.30	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	8.34	3.73	0.44	0.88	1.76	1.54	0.00	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	11.32	3.52	2.51	0.50	2.51	2.01	0.25	0.50	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	9.83	2.40	3.71	1.31	1.97	1.53	0.22	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	9.28	3.37	1.69	3.37	1.27	2.95	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	10.66	3.20	2.67	2.13	1.07	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.03	3.61	2.86	0.90	0.45	1.35	0.30	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	9.76	3.88	3.07	2.41	1.60	1.47	0.27	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.36	3.11	2.76	3.28	1.04	0.86	0.00	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.18	3.49	2.07	1.81	1.81	0.90	0.13	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	8.98	3.64	2.91	1.94	2.43	1.46	0.24	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	7.74	2.58	1.29	3.10	1.55	2.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	9.50	3.80	2.85	1.27	1.27	1.27	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	7.69	4.95	1.65	1.10	1.65	2.75	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	8.72	2.83	2.59	2.12	2.12	2.12	0.47	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	8.08	3.55	2.75	2.10	1.62	0.97	0.16	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.60	2.90	1.63	0.18	0.54	1.81	0.54	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	12.35	3.56	2.72	1.26	0.84	0.84	0.21	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.79	1.95	1.95	1.37	1.17	1.56	0.39	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.50	2.74	2.32	2.95	1.90	2.53	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.58	3.13	1.48	1.98	1.32	0.99	0.00	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.79	2.62	2.62	1.68	1.50	1.87	0.19	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.81	3.64	3.64	0.96	1.53	0.57	0.57	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	7.15	2.66	1.84	2.04	1.84	2.45	0.41	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	10.07	4.23	1.21	1.01	1.01	1.61	0.20	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	6.21	3.51	1.35	1.35	1.35	1.62	0.27	0.54	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	6.00	3.60	1.68	1.92	0.72	0.96	0.00	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	9.41	3.06	1.65	1.18	0.94	2.12	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	10.54	2.49	1.76	1.46	1.46	1.46	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	8.01	3.37	2.53	2.32	1.48	1.69	0.00	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	9.97	3.85	2.27	2.45	1.75	1.57	0.00	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.83	3.21	1.61	1.41	1.41	1.00	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	12.33	4.89	4.42	2.56	3.02	1.40	0.23	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	13.91	3.84	1.92	2.16	2.40	1.68	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	13.11	5.07	2.68	3.28	1.79	1.79	0.60	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	17.95	8.86	3.35	6.70	3.83	1.44	0.72	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	16.38	8.09	3.84	4.85	3.84	2.02	1.01	0.40	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	21.52	11.89	2.87	6.35	3.07	3.28	0.41	0.41	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	27.13	12.90	4.45	6.45	1.78	3.34	0.44	1.11	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	13.99	0.00	27.98	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	33.36	10.29	2.84	6.74	4.61	2.13	0.71	1.42	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	30.82	11.60	3.65	6.63	6.30	1.66	0.00	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	20.97	6.71	0.00	5.87	0.84	0.00	0.84	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	20.67	8.73	2.76	5.05	1.38	1.38	1.84	0.92	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	52.18	13.61	8.43	12.96	4.54	2.59	0.97	1.62	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	40.15	10.60	7.39	8.03	4.50	2.57	0.96	2.25	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	37.72	11.63	2.83	5.34	2.83	1.89	1.57	0.63	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	44.42	13.40	5.64	9.17	6.35	3.53	2.82	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	65.05	6.73	7.29	9.53	5.61	2.80	0.56	0.56	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	35.83	6.37	0.80	6.37	1.59	0.80	0.00	0.00	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	30.24	9.51	2.38	8.15	4.08	1.36	0.34	1.02	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	46.79	9.75	8.77	11.70	5.20	3.25	1.62	1.30	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	44.02	7.10	9.94	9.23	7.81	2.48	1.06	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	0.00	0.00	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	15.79	7.90	7.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	45.83	6.83	10.24	6.83	5.85	3.41	1.95	0.49	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	32.23	9.42	7.44	7.44	4.46	2.98	1.49	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	31.43	7.51	7.97	8.44	5.16	0.00	0.47	1.88	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	23.85	6.29	6.95	3.64	3.97	1.66	0.99	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	33.10	5.57	8.35	8.04	6.50	1.55	0.31	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.66	6.11	7.95	5.81	4.89	1.83	0.00	0.61	0.92
Adipocyte - breast, donor1	11376-118A8	10.29	10.29	6.65	8.24	6.34	1.74	1.43	0.32	0.63
Adipocyte - breast, donor2	11327-117E4	16.52	12.99	6.90	8.50	5.78	1.76	0.96	0.48	0.64
Adipocyte - omental, donor1	11473-119C6	14.25	10.94	6.74	6.11	4.33	2.29	0.76	0.64	0.38
Adipocyte - omental, donor2	11474-119C7	10.46	12.71	9.72	5.23	2.99	2.24	1.49	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	9.04	8.04	8.04	3.68	3.01	0.67	0.00	0.33	0.67
Adipocyte - perirenal, donor1	11476-119C9	13.40	8.93	8.93	5.10	1.91	0.00	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	8.80	2.20	7.70	5.50	2.20	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	32.97	11.74	8.58	11.29	9.48	2.26	3.16	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	12.51	11.12	5.91	4.69	5.91	1.74	0.35	0.70	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	15.06	8.80	5.87	3.91	4.11	1.56	0.59	0.00	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	6.43	4.63	2.06	1.54	2.32	0.26	0.00	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	15.33	9.48	1.95	5.85	6.13	2.51	1.12	0.56	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	17.63	10.58	7.64	4.11	1.18	4.11	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	11.18	11.18	3.86	5.95	3.06	1.61	0.56	0.40	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	11.62	7.10	4.20	3.23	0.65	1.29	0.65	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	10.66	6.40	2.13	8.00	1.07	0.53	0.53	1.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	16.14	7.79	5.01	5.01	1.67	0.56	0.00	1.67	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	8.32	9.57	4.99	4.99	3.74	1.25	0.42	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	10.05	9.54	3.52	3.27	3.77	0.75	0.25	0.50	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	12.76	7.85	1.64	3.60	1.64	1.31	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	7.92	5.78	0.91	1.22	1.83	0.61	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	39.12	11.27	7.51	8.84	6.63	0.88	5.08	0.00	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	42.67	16.49	17.93	13.27	12.91	2.15	8.25	0.36	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	33.54	7.19	9.58	14.38	3.59	2.40	5.99	0.00	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	18.89	10.79	5.04	4.50	4.14	1.44	0.54	0.18	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	10.04	8.37	5.02	1.67	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	15.82	12.33	6.99	5.75	2.88	1.03	0.41	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	5.61	3.78	3.32	3.55	2.63	1.72	1.83	0.57	0.00
Anulus Pulposus Cell, donor2	11463-119B5	4.65	3.43	5.39	3.67	1.96	1.22	0.49	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.48	6.29	8.54	6.74	4.49	1.35	2.25	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	14.76	7.38	9.12	7.38	3.91	2.60	0.43	1.30	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	14.98	12.84	6.42	2.14	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	11.96	5.98	5.68	8.07	5.68	1.20	1.49	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	16.44	3.79	6.32	7.59	5.06	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.84	2.64	8.58	9.24	3.96	0.66	0.00	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	14.62	5.52	5.52	5.85	4.55	0.00	1.30	0.65	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	13.59	3.88	10.68	8.25	4.37	1.46	0.49	1.46	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.07	5.94	9.50	5.34	2.38	1.78	1.78	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	10.92	7.16	4.14	6.40	3.39	0.75	0.75	0.38	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.79	5.08	5.81	7.26	5.08	1.45	0.73	2.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	15.05	2.51	3.76	6.27	1.25	1.25	1.25	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	21.91	8.07	11.70	8.90	4.94	1.15	1.15	0.82	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	13.65	10.92	9.55	9.55	4.09	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	14.48	6.33	5.73	4.98	3.62	1.51	0.75	0.45	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	11.79	4.29	7.50	6.43	2.68	1.61	1.61	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	12.09	4.53	7.56	6.05	5.48	0.76	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	14.17	7.48	10.42	7.75	4.54	1.60	1.34	0.80	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	0.00	12.68	0.98	1.95	1.95	3.90	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.77	5.31	7.80	5.97	4.15	1.66	1.00	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	16.81	6.00	7.20	4.80	0.00	1.20	3.60	1.20	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	7.08	3.54	0.00	7.08	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.75	4.63	10.98	6.18	4.29	1.54	0.86	0.17	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	8.39	8.39	4.19	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.19	4.37	7.77	6.31	1.94	1.46	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	15.56	3.42	11.38	6.07	6.83	0.38	1.14	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	3.63	9.69	12.11	10.90	2.42	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	12.54	5.13	7.98	5.13	2.28	1.14	1.71	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	13.47	6.41	9.83	6.84	5.99	1.28	1.28	0.00	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.94	6.45	5.42	5.68	4.13	1.81	1.81	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	17.36	9.85	8.45	7.04	3.28	1.41	1.88	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	19.29	8.36	11.90	5.79	4.82	1.61	1.61	0.96	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	18.55	4.99	4.28	6.42	3.57	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	14.62	7.60	8.19	7.02	8.19	1.75	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	16.86	7.23	10.24	6.32	2.11	1.51	0.90	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	11.88	7.13	8.32	2.38	2.38	4.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.73	4.58	9.15	6.10	2.03	1.53	1.02	1.53	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.26	6.62	7.39	5.35	6.88	1.78	2.29	1.27	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	13.98	5.72	6.35	4.45	2.54	1.27	0.00	1.91	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	11.22	6.47	4.32	6.47	4.32	1.73	0.00	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	13.55	4.23	8.47	5.50	6.14	0.64	0.85	0.21	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	13.92	5.51	7.54	6.09	3.77	1.16	1.45	0.29	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	18.89	6.61	9.45	11.34	2.83	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.26	5.26	7.97	4.92	4.75	0.85	1.02	0.34	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	4.63	6.95	4.63	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	4.23	8.45	6.34	2.11	2.11	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.65	4.72	7.29	4.50	4.93	1.50	1.07	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	7.82	4.21	7.22	7.22	3.01	0.00	1.20	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.12	3.64	7.29	7.29	1.46	1.46	2.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	13.33	6.21	6.90	5.29	3.68	0.92	2.07	0.92	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	10.20	5.10	5.10	2.55	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.69	3.56	6.61	5.85	3.56	0.51	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	13.01	4.75	8.46	4.13	5.78	1.86	0.83	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	13.46	3.67	7.04	5.51	3.06	0.92	1.53	0.61	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	12.91	8.13	9.08	6.69	4.78	2.39	2.39	0.48	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.53	6.21	8.20	8.65	4.66	1.77	1.11	0.44	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	0.00	3.05	6.10	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	15.51	3.32	7.20	3.88	4.43	2.22	1.11	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	12.45	5.03	7.94	5.83	3.18	1.32	2.65	1.06	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	12.36	9.81	6.54	6.54	5.09	2.54	1.09	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	23.09	9.58	14.00	5.77	5.77	4.18	1.84	1.47	0.61
Astrocyte - cerebellum, donor2	11580-120F5	22.94	10.61	11.98	8.22	9.76	3.42	2.91	1.03	0.86
Astrocyte - cerebellum, donor3	11661-122F5	21.60	13.21	6.92	6.92	3.57	3.36	0.63	0.42	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	22.31	11.15	8.37	7.32	4.88	1.39	1.05	0.70	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	24.75	8.25	8.25	9.06	5.99	2.10	1.13	0.97	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	42.51	9.99	11.78	7.16	8.05	4.18	1.79	0.89	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	34.64	13.19	9.06	4.47	5.16	4.24	1.15	1.72	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	41.22	15.41	9.15	5.14	6.89	3.38	1.75	1.25	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	33.23	13.09	9.45	6.49	5.23	3.19	2.16	1.14	0.23
Basophils, donor1	12241-129G9	8.63	21.18	1.31	4.18	1.05	1.31	0.00	0.26	0.78
Basophils, donor2	12242-129H1	8.30	17.32	1.44	5.41	1.44	1.08	0.00	0.00	0.72
Basophils, donor3	12243-129H2	8.67	13.52	1.32	3.09	2.20	2.06	0.00	0.00	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	17.68	7.55	5.17	4.74	2.16	1.29	2.37	0.65	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	53.49	16.00	21.49	21.49	10.52	2.29	4.57	3.20	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	7.17	14.35	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	17.57	7.53	11.93	8.79	5.02	0.00	3.14	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	19.13	9.98	10.81	7.49	6.45	0.42	3.12	1.04	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	26.94	22.11	14.97	15.89	7.60	2.53	2.76	1.15	1.61
Bronchial Epithelial Cell, donor7	11769-123I5	19.43	4.14	7.38	8.28	2.70	1.80	0.90	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	50.91	12.26	2.16	1.55	1.24	4.64	0.21	0.93	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	49.38	13.74	10.01	3.73	4.43	2.56	0.93	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.86	15.03	6.08	4.16	2.24	10.23	0.00	1.28	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	8.45	15.78	1.13	1.69	1.69	0.56	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	3.53	9.09	0.93	1.30	0.74	1.67	0.00	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	5.49	11.64	2.20	1.54	1.32	1.54	0.44	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	10.76	15.00	1.98	1.42	0.85	1.98	0.00	0.85	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	18.95	21.99	2.65	1.90	2.65	3.79	0.00	1.14	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	14.46	17.75	1.97	2.96	0.33	2.63	0.00	1.31	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	9.54	12.72	2.17	3.32	1.88	1.88	0.14	0.87	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	6.94	9.35	1.81	2.41	1.51	2.11	0.00	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	6.63	10.19	0.71	2.13	0.95	0.95	0.00	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.01	7.03	0.84	2.01	0.67	1.34	0.17	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	6.35	5.52	0.83	1.38	0.00	0.83	0.55	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	6.94	4.71	1.24	1.24	0.00	0.99	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	3.72	3.33	0.00	1.37	0.98	1.37	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.27	3.20	1.25	1.78	1.42	0.89	0.00	0.53	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	4.35	4.57	0.65	1.96	0.87	1.09	0.00	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.02	5.15	0.70	0.94	0.23	0.00	0.00	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	10.03	2.11	1.58	3.17	0.53	1.06	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	4.44	0.00	2.22	0.00	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	5.06	8.92	1.93	3.72	0.45	1.04	0.30	0.30	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.59	7.98	1.20	2.59	0.60	1.20	0.20	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	5.20	7.50	1.25	1.87	0.42	0.42	0.00	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	7.78	6.18	0.92	1.37	0.23	0.69	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.79	6.11	0.23	1.13	0.23	2.04	0.00	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	6.55	2.62	1.75	0.44	0.44	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.57	5.92	1.34	2.96	0.54	2.42	0.54	0.00	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	5.23	7.15	2.09	2.79	1.05	1.22	0.00	0.00	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	6.73	6.73	0.84	3.37	0.42	0.84	0.00	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.86	4.04	0.92	1.10	0.37	1.29	0.00	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.93	3.52	0.00	0.35	0.00	0.70	0.00	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.70	3.95	1.32	0.44	0.00	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	3.49	4.01	0.52	1.57	0.52	1.05	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.09	2.60	0.74	0.74	0.74	0.37	0.00	0.74	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	7.76	5.39	0.65	1.29	0.86	2.16	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.55	5.32	1.23	0.82	0.00	1.23	0.00	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.26	5.10	0.70	1.39	0.23	0.93	0.00	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.82	7.42	0.46	1.86	0.23	0.70	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	24.41	25.28	4.80	8.28	3.92	4.58	0.44	0.22	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	22.64	16.63	4.62	7.85	2.77	1.85	0.46	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	23.18	17.55	7.36	6.28	4.98	4.55	0.00	0.22	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	18.22	26.01	4.36	5.29	2.80	7.47	0.00	2.18	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	11.35	14.50	2.79	3.14	2.45	3.14	0.17	0.70	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	14.72	13.60	4.01	3.57	2.68	4.24	0.00	0.67	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	44.91	31.39	6.38	11.23	4.34	3.57	0.26	1.79	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	28.76	21.96	5.27	9.00	4.39	4.17	1.54	1.54	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	38.74	21.90	5.47	8.00	4.63	4.00	0.63	1.47	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	73.16	22.36	12.19	8.13	4.06	12.19	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	70.51	20.34	1.36	8.14	7.46	4.07	1.36	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	64.21	11.39	4.14	5.18	6.21	7.25	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	70.89	23.99	6.40	9.06	5.86	7.46	2.13	1.07	4.26
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	65.40	15.55	6.43	3.75	3.22	5.36	1.07	2.68	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	63.17	16.85	4.21	9.13	1.40	6.32	1.40	2.81	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	76.08	18.82	3.92	7.06	5.49	6.27	0.78	1.57	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	81.73	13.18	6.59	7.91	3.95	7.91	0.00	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	10.68	9.04	0.00	3.29	0.00	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	15.23	6.53	0.73	0.00	0.00	1.45	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	10.10	10.60	0.00	1.01	1.01	2.02	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	10.91	14.55	4.04	0.81	1.62	5.66	0.00	1.21	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	10.79	14.78	2.40	3.20	2.00	5.99	0.00	2.40	0.00
CD34+ Progenitors, donor1	11545-120B6	11.04	13.05	0.00	3.01	2.01	6.02	1.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	6.18	16.85	1.12	5.06	1.12	2.25	0.00	1.12	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	34.57	19.16	6.39	4.13	4.88	7.14	0.00	0.75	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	44.42	16.69	6.31	7.22	2.93	7.67	0.45	0.90	0.00
CD4+ T Cells, donor1	11225-116C1	5.00	26.42	0.00	0.36	0.00	1.43	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	4.90	20.21	1.84	1.22	0.61	1.22	0.00	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	11.28	22.87	0.91	3.35	0.30	3.05	0.00	1.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	62.79	16.08	9.70	10.98	4.34	7.91	0.51	1.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	66.71	21.79	6.29	11.68	6.29	8.31	0.67	1.80	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	57.20	17.82	4.89	8.34	2.87	6.32	1.44	1.72	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	26.55	52.62	2.37	3.32	0.95	7.59	0.00	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	21.77	41.44	2.11	4.21	2.11	11.24	0.00	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	23.07	26.37	0.00	3.30	0.00	9.89	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	81.94	27.89	16.47	14.60	11.13	4.91	3.32	1.59	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	88.97	26.10	10.00	12.88	10.17	9.83	2.54	2.20	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	69.16	18.70	9.51	10.80	9.03	3.87	2.10	1.77	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	34.07	42.59	2.24	6.28	2.69	4.03	0.00	1.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	41.58	33.19	6.29	6.29	3.14	8.73	0.00	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	41.36	21.12	3.96	4.40	1.76	4.84	0.00	1.32	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	104.15	44.27	14.76	21.08	9.28	12.65	0.42	2.53	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	105.13	33.04	19.53	18.49	12.26	9.35	2.70	3.74	2.70
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	109.93	33.41	25.73	16.37	12.03	6.68	1.34	2.34	2.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	22.03	48.68	0.82	2.18	0.82	4.35	0.00	0.82	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	21.44	35.37	1.07	1.07	0.00	3.22	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	21.52	34.07	1.79	1.79	1.79	3.59	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	116.63	37.83	20.03	21.88	13.17	8.90	1.11	2.97	2.41
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	108.31	34.44	15.60	18.20	13.43	9.96	1.73	1.95	1.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	108.23	41.82	17.65	15.97	12.61	11.14	2.10	2.52	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	39.44	36.91	4.04	2.02	3.54	9.10	0.51	2.02	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	31.19	39.43	3.03	2.17	2.17	6.50	0.00	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	30.07	30.51	1.74	1.74	0.87	6.54	0.00	1.74	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	65.82	30.68	4.95	5.44	6.93	10.39	0.49	3.46	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	61.85	25.85	4.62	5.54	6.46	5.54	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	80.96	36.29	5.58	6.98	6.98	16.75	0.00	2.79	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	35.72	28.52	6.37	7.20	3.60	9.42	0.00	1.38	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	35.83	25.52	4.66	3.44	3.19	6.38	0.00	2.70	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	53.90	30.80	3.08	12.32	9.24	3.08	1.54	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	69.12	29.37	7.16	7.16	3.94	7.16	1.07	2.15	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	96.95	26.31	6.92	16.62	8.31	4.15	0.00	4.15	1.38
CD8+ T Cells, donor1	11226-116C2	11.79	23.90	1.31	4.26	1.31	2.62	0.65	0.00	1.64
CD8+ T Cells, donor2	11307-117C2	11.26	15.02	1.13	4.13	0.75	1.13	0.00	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	9.59	25.00	1.77	3.28	1.01	1.77	0.00	0.50	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	61.71	11.01	8.72	13.76	3.67	0.46	7.34	0.46	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	50.09	18.69	10.06	14.38	4.31	1.68	6.47	0.48	1.68
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	44.32	14.23	9.58	17.24	3.56	1.64	4.65	0.27	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	35.42	8.71	6.00	8.11	4.80	1.50	6.30	0.60	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	45.12	12.96	8.16	13.92	4.56	2.40	5.04	0.72	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	43.20	13.64	9.32	10.00	4.32	1.36	2.96	0.68	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	45.20	11.30	7.39	13.04	5.87	0.65	5.65	0.00	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	54.48	10.79	7.63	13.95	8.16	0.53	7.37	0.00	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	47.61	10.55	7.97	11.96	4.69	1.17	7.97	0.47	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	72.75	18.41	13.89	20.53	7.25	0.60	5.13	0.60	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	66.53	18.01	11.04	19.75	5.52	0.29	6.97	1.16	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	61.55	21.05	11.99	17.58	8.53	1.33	5.86	0.27	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	62.16	9.19	7.00	6.57	1.75	0.88	3.94	0.44	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	68.31	13.21	10.93	9.11	5.47	0.46	4.55	0.00	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	67.87	9.70	4.48	8.95	5.97	1.49	3.73	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	57.99	12.61	11.52	10.44	4.68	0.72	2.52	0.36	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	46.32	12.95	8.34	11.80	5.18	0.58	4.03	1.15	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	40.78	9.90	8.96	11.08	4.48	2.59	3.77	0.94	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	55.46	7.61	10.77	16.16	6.02	0.95	3.17	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	48.29	8.30	7.07	12.61	5.23	0.31	4.00	0.62	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	48.73	8.66	7.69	9.62	6.41	0.32	3.21	0.32	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	64.64	13.39	12.24	14.15	6.50	1.91	4.59	0.38	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	59.51	13.40	7.49	14.19	8.67	1.97	5.52	0.00	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	55.97	18.15	10.59	9.08	8.32	3.78	4.54	0.76	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	68.25	16.86	4.01	3.21	0.80	0.00	3.21	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	67.84	14.69	9.79	6.29	4.20	0.70	3.50	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	64.11	13.02	5.01	6.01	5.01	0.00	5.01	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	5.48	5.48	3.66	3.66	0.00	5.48	1.83	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	17.29	6.42	7.91	6.42	4.94	0.49	0.99	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	17.99	6.63	7.16	4.95	5.68	1.79	1.26	0.53	0.63
Chondrocyte - de diff, donor1	11261-116G1	9.36	7.28	4.85	4.16	3.81	1.39	2.08	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	8.53	4.98	2.13	1.42	2.13	0.36	1.07	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	14.45	8.31	4.32	4.55	3.87	1.93	0.68	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	8.06	4.48	7.16	5.37	3.58	1.79	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	12.13	6.87	4.45	3.24	1.21	2.02	2.43	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	20.54	6.43	6.08	6.08	5.74	2.98	1.38	0.69	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	22.02	6.63	9.62	6.63	2.78	2.14	2.35	0.64	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	27.61	5.13	7.17	6.19	5.58	1.86	0.80	0.35	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	20.08	14.03	3.76	3.94	2.57	1.83	1.10	0.73	0.18
Corneal Epithelial Cells, donor1	11526-119I5	28.76	9.66	11.64	9.00	4.39	1.76	1.10	0.22	0.88
Corneal Epithelial Cells, donor2	11606-120I4	21.61	5.69	4.55	6.83	1.14	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	23.26	11.25	5.88	6.14	5.11	1.79	2.81	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	10.40	11.72	2.48	2.97	2.31	0.99	0.00	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	10.09	12.93	5.36	2.84	0.63	1.89	0.00	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	3.45	0.00	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	16.31	9.94	2.81	2.92	2.48	0.76	0.11	0.76	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	77.55	28.70	15.03	11.27	8.54	17.08	0.34	1.71	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	71.16	24.81	12.40	10.45	5.88	12.40	0.00	3.26	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	63.40	27.58	18.39	12.58	4.36	17.42	0.48	2.42	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	17.68	10.17	5.34	3.34	6.00	0.83	0.33	0.17	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	17.02	5.87	7.04	4.69	3.52	0.59	1.17	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	39.87	8.48	11.03	7.07	9.62	2.55	1.13	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	19.27	10.62	5.50	9.44	3.54	1.18	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	23.27	7.85	6.98	5.82	5.82	1.45	0.87	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	36.23	9.88	15.76	10.12	12.00	1.88	0.71	0.71	0.94
Endothelial Cells - Artery, donor3	11413-118E9	23.14	10.34	5.96	7.19	5.79	1.93	1.93	0.18	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	16.18	7.98	6.21	3.55	4.65	0.89	0.00	0.00	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	17.04	8.22	8.22	1.83	3.04	0.30	0.30	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	23.12	8.46	7.05	3.10	2.54	1.41	0.28	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	24.96	9.21	9.81	5.65	4.75	1.49	1.49	0.89	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	16.66	6.25	6.77	5.21	4.69	0.00	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	30.91	8.93	5.96	6.38	4.25	1.70	0.14	0.99	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	13.20	8.00	12.00	2.00	7.60	2.00	3.20	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	22.54	8.91	11.53	6.29	7.34	0.52	0.52	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	36.03	13.17	9.57	7.83	9.82	1.86	1.24	0.62	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	20.86	8.69	7.82	7.17	4.78	0.87	1.30	0.65	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	34.68	8.92	9.28	5.50	6.84	2.08	1.95	0.24	0.49
Endothelial Cells - Vein, donor1	11267-116G7	40.95	6.83	10.24	3.41	11.38	0.00	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	18.16	12.57	5.59	4.89	7.68	1.40	0.70	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	26.38	8.95	7.85	3.77	9.42	1.41	0.63	0.47	0.63
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	9.90	3.30	0.00	8.25	0.00	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	14.27	0.00	0.00	7.13	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	27.61	6.11	9.04	7.57	3.91	0.49	3.42	0.49	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	29.12	2.08	4.16	2.08	4.16	0.00	0.00	4.16	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	4.52	2.46	2.46	2.87	4.11	1.23	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	10.84	3.94	4.71	3.83	3.39	0.99	0.77	0.44	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	21.99	11.38	7.04	6.72	5.42	1.52	1.63	0.98	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	18.68	11.16	7.03	6.43	6.06	0.97	1.21	0.61	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	4.37	6.00	2.59	2.46	0.82	0.82	0.96	0.00	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	13.29	8.65	5.17	3.80	3.59	1.37	0.74	0.21	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	2.90	4.48	3.16	1.58	0.79	1.32	0.00	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	26.58	11.63	9.97	6.64	3.99	1.99	1.00	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	11.79	6.35	5.44	6.80	6.35	0.45	0.45	0.45	0.91
Fibroblast - Cardiac, donor2	11345-117G4	25.01	16.67	9.10	4.55	3.03	0.00	2.27	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	28.70	10.41	11.83	8.52	6.78	2.05	1.73	1.10	1.10
Fibroblast - Cardiac, donor4	11452-119A3	7.88	9.40	5.15	4.85	2.42	0.30	0.61	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	9.26	8.25	5.58	3.68	4.19	0.63	0.76	0.63	0.00
Fibroblast - Cardiac, donor6	11460-119B2	14.10	5.61	4.85	6.06	5.46	0.61	0.76	0.45	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.94	10.72	8.31	7.37	2.81	2.28	0.94	0.13	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.94	6.47	3.88	3.88	4.31	0.86	0.43	0.00	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	45.41	11.72	11.72	8.79	13.18	2.93	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	15.68	14.76	7.38	5.07	4.38	2.54	0.69	0.92	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	12.21	5.77	8.48	4.07	2.04	2.54	1.02	0.85	0.00
Fibroblast - Dermal, donor1	11269-116G9	6.57	3.52	2.35	1.41	1.88	0.94	0.23	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	9.43	6.13	5.19	2.36	2.83	0.47	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	7.13	5.32	3.87	2.66	3.02	1.33	0.00	0.24	0.36
Fibroblast - Dermal, donor4	11450-119A1	11.19	6.22	4.63	3.50	4.86	1.81	0.45	0.90	0.34
Fibroblast - Dermal, donor5	11454-119A5	10.82	3.84	6.98	3.84	4.71	1.05	1.22	0.52	0.52
Fibroblast - Dermal, donor6	11458-119A9	14.78	6.82	7.96	5.68	5.04	2.92	0.81	0.97	0.16
Fibroblast - Gingival, donor1	11237-116D4	8.95	5.21	5.83	2.29	2.08	1.25	0.83	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	7.60	7.07	4.98	3.14	4.98	2.36	0.52	0.79	0.26
Fibroblast - Gingival, donor2	11318-117D4	20.16	9.09	7.51	8.30	4.74	1.71	1.58	1.32	0.40
Fibroblast - Gingival, donor3	11394-118C8	8.03	6.77	3.29	1.06	2.71	1.16	0.19	0.39	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	13.51	6.23	6.23	1.04	5.19	1.04	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	8.28	3.17	3.17	3.00	1.59	0.35	0.35	1.06	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	17.77	11.38	6.39	5.92	4.68	3.43	2.34	0.78	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	13.79	9.60	9.20	7.57	4.33	1.22	2.03	0.68	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	29.99	25.41	15.17	11.65	11.29	4.23	2.47	2.12	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	14.62	10.97	6.14	6.14	5.70	1.61	1.75	1.02	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	14.73	10.36	5.59	6.00	4.36	2.05	0.55	1.36	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	23.04	10.86	7.57	8.45	5.37	2.19	1.76	0.99	1.86
Fibroblast - Gingival, donor9 (control)	11927-125I1	4.70	6.75	2.79	2.93	1.47	2.20	0.15	0.59	0.29
Fibroblast - Lung, donor1	11270-116H1	8.16	5.44	9.52	5.44	4.08	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	8.95	4.48	0.00	0.00	4.48	7.46	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	14.77	7.39	9.71	5.70	5.91	1.90	1.69	0.42	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	13.33	9.16	10.83	5.83	2.50	0.83	1.67	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	5.59	4.20	2.80	0.00	2.80	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	8.96	6.16	6.16	1.96	2.24	1.96	0.56	1.40	0.00
Fibroblast - Mammary, donor1	11540-120B1	15.43	9.34	12.99	4.87	6.09	4.47	1.62	1.22	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	11.98	0.00	0.00	0.00	3.99	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	17.87	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	14.35	8.73	5.43	4.85	3.49	0.97	0.78	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	20.93	5.76	7.74	6.22	6.67	1.52	1.21	0.15	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	18.67	4.90	11.32	4.59	2.45	0.31	1.84	0.61	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	11.83	4.96	4.20	4.20	3.82	2.29	0.76	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.01	8.91	6.21	6.21	5.13	1.89	0.81	0.54	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	11.71	10.67	5.80	4.52	3.71	0.93	0.70	0.12	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	31.72	12.82	10.17	9.84	8.51	1.44	2.21	0.11	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	24.18	13.61	13.61	6.91	6.71	1.63	1.63	1.02	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	11.36	6.01	8.69	6.68	3.34	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	19.77	6.33	4.74	6.33	4.35	1.58	1.19	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	3.37	6.55	3.57	3.97	1.59	1.19	0.79	0.60	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	6.22	3.55	1.95	2.31	1.60	2.31	0.00	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	7.29	3.94	3.74	2.56	1.38	2.17	0.00	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1.81	4.81	1.81	1.50	0.30	1.81	0.90	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	7.02	3.78	4.53	2.91	1.84	1.30	1.08	0.76	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	4.05	6.83	1.01	1.27	2.53	0.76	0.25	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	10.17	7.88	3.61	2.79	1.48	1.64	0.49	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	4.81	7.62	2.21	2.21	2.61	0.80	0.00	0.40	0.00
Fibroblast - skin normal, donor2	11561-120D4	9.24	9.34	7.23	4.82	3.42	2.51	1.00	0.80	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	1.81	10.58	0.91	0.30	2.12	1.21	0.00	0.00	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	7.46	5.30	3.15	2.24	2.49	1.74	0.33	0.41	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	3.08	3.93	3.08	3.59	0.85	1.03	0.17	0.68	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	2.96	8.87	1.64	2.30	0.66	0.99	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	13.63	8.31	7.67	5.43	3.41	2.02	1.17	0.75	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	18.55	7.76	6.58	6.58	3.20	2.02	1.69	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.41	3.92	2.35	3.45	2.04	0.63	0.78	0.94	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	6.97	2.61	0.00	0.87	0.87	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	19.59	6.76	4.16	5.37	4.85	1.21	1.04	0.52	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	27.33	11.45	9.89	7.55	9.11	0.26	1.04	0.78	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	13.54	5.88	3.58	3.83	2.30	0.77	1.28	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	13.01	4.59	10.72	3.06	0.77	1.53	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	16.59	7.66	5.10	3.19	5.10	3.83	3.83	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	24.25	7.99	6.56	2.85	4.56	2.28	1.14	0.86	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	16.82	6.07	5.79	1.10	1.10	6.89	0.28	0.83	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	21.46	5.25	3.88	2.05	2.28	2.05	0.00	0.91	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	27.14	3.57	9.11	3.17	2.38	2.38	1.39	0.79	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	14.80	6.61	6.87	2.38	1.59	2.91	0.00	0.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	23.48	4.89	6.85	1.63	2.28	2.94	0.33	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	21.23	4.86	8.40	3.98	3.10	0.44	1.77	1.33	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	22.75	5.94	9.89	4.10	4.38	1.41	2.40	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	25.49	6.65	5.54	3.08	5.17	2.71	0.37	0.49	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	22.03	4.84	8.60	5.91	2.69	1.34	0.81	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	33.95	7.19	7.81	5.95	6.44	2.48	1.12	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	26.85	5.68	6.23	3.88	6.09	1.80	1.94	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	19.31	5.08	6.30	4.47	3.46	1.42	2.03	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	28.98	5.25	7.30	5.48	6.62	4.79	0.68	1.14	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	24.41	5.36	6.85	4.24	5.11	0.62	1.12	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	33.44	5.46	6.34	3.93	4.15	2.19	1.75	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	30.14	6.50	6.80	3.84	5.32	3.55	0.30	0.89	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	27.66	4.93	6.84	5.25	5.72	3.18	0.32	0.48	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	34.63	8.49	7.15	4.92	6.26	1.56	1.12	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	29.04	5.44	7.86	5.44	5.24	4.03	1.01	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	29.86	10.52	7.12	4.58	4.41	2.71	1.53	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	48.50	9.22	9.40	10.73	6.47	2.13	4.26	1.15	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	34.75	10.30	13.63	8.32	6.35	4.89	0.62	0.62	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	27.84	7.34	7.68	3.59	5.12	5.64	0.51	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	19.59	6.20	5.98	4.09	5.31	2.55	0.11	0.77	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	33.03	6.66	8.90	6.99	5.99	2.16	1.58	0.33	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.42	6.53	7.55	6.94	5.51	3.27	1.84	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	24.76	6.81	6.60	4.33	5.16	3.71	0.21	0.62	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	17.76	5.88	6.92	3.80	5.65	2.88	0.58	0.58	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	28.02	5.34	5.67	6.17	5.50	1.33	1.17	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	23.81	5.73	9.92	3.75	4.63	2.65	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	20.05	7.38	6.03	3.81	4.30	3.20	0.37	0.98	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	32.74	6.00	9.56	6.97	5.84	2.11	1.62	0.65	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	24.05	5.77	5.45	3.85	2.25	4.81	0.32	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.71	7.30	6.25	3.13	5.59	2.08	0.19	0.57	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	22.14	6.49	7.43	3.48	5.69	1.42	0.95	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	18.85	6.99	4.87	3.34	4.26	2.74	1.22	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	18.71	8.78	7.74	5.54	4.81	2.30	1.15	0.52	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	22.83	3.95	7.46	4.39	3.51	1.54	1.98	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	26.93	5.33	5.89	3.09	4.21	1.96	0.00	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	18.70	8.06	8.24	4.91	6.20	1.39	0.83	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	28.08	8.82	7.49	8.56	5.88	1.87	1.60	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	28.31	9.95	6.27	6.58	6.73	1.53	1.38	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	25.52	10.88	9.97	6.48	6.48	1.17	1.68	0.91	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.02	6.51	9.22	7.32	6.78	2.17	0.54	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	25.62	8.11	10.32	8.85	7.37	2.21	1.11	0.74	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	22.59	10.53	7.68	7.68	5.26	3.29	0.88	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	22.81	9.92	6.94	3.97	6.94	0.99	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	35.88	11.34	11.21	13.32	8.05	1.71	1.71	1.06	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.68	10.29	14.32	12.31	8.68	2.62	1.61	1.21	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	30.50	12.20	10.42	8.13	10.17	5.59	1.27	0.76	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	17.12	7.37	12.34	3.38	5.77	1.59	0.60	0.80	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	24.96	5.24	9.71	2.77	4.78	1.39	0.15	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	21.69	8.39	9.41	4.30	6.75	2.05	0.61	0.82	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	31.61	6.26	7.82	5.95	6.88	2.50	0.31	1.56	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	33.62	5.65	7.91	5.93	5.65	2.83	1.98	0.28	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	15.22	5.53	6.46	5.07	4.15	1.84	0.46	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	49.50	19.80	12.37	0.00	9.90	2.47	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	27.85	7.35	7.35	6.58	4.64	2.32	1.16	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	32.09	8.02	8.02	14.44	8.02	1.60	3.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	48.69	8.69	10.43	3.48	15.65	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	27.99	5.21	9.76	5.21	3.91	2.60	0.98	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	24.30	4.53	3.71	7.00	4.12	1.65	1.24	0.41	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	3.33	6.66	3.33	10.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	17.34	4.75	10.07	4.75	6.71	1.40	0.28	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	33.66	8.17	9.15	6.21	5.56	1.96	0.65	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	15.94	4.19	10.90	2.52	7.55	2.52	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	22.90	7.95	12.40	3.50	6.04	1.91	0.64	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	23.44	4.08	8.83	7.13	4.42	2.04	0.68	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	25.06	4.18	6.26	12.53	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	18.33	4.58	10.88	6.30	4.58	3.44	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	23.97	4.44	4.74	4.44	7.40	2.37	0.00	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	33.88	5.08	1.69	8.47	0.00	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	19.05	6.63	7.87	6.63	5.80	3.31	0.41	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	29.00	5.06	5.52	5.52	4.60	3.22	0.00	0.46	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	10.54	0.00	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	23.06	3.46	5.00	5.77	3.08	3.08	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	21.19	3.91	5.54	1.96	1.96	1.30	1.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	17.39	4.68	6.69	4.01	6.02	0.67	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	21.58	5.78	6.55	5.78	3.85	4.24	0.39	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	16.77	4.79	4.11	3.42	3.08	0.68	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	0.00	2.48	0.00	0.00	2.48	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	18.40	1.89	2.83	0.94	4.72	6.61	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	18.10	3.62	4.83	4.83	2.41	3.62	1.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	17.29	2.54	6.61	2.54	4.07	2.54	0.00	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	16.35	5.58	3.99	3.99	3.19	0.40	0.00	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	21.21	2.47	3.95	5.43	4.93	0.99	0.99	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	25.97	3.54	4.72	3.54	1.18	2.36	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	21.00	2.92	4.08	3.50	1.75	4.08	0.00	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	28.53	4.39	4.83	5.27	2.63	3.51	0.00	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	16.95	0.85	5.09	3.39	3.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	11.94	5.37	2.98	8.95	1.79	3.58	0.00	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	18.92	5.82	6.79	6.79	3.40	1.46	0.49	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	12.55	9.13	5.71	1.14	4.57	1.14	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	20.79	11.23	10.40	8.73	6.65	2.91	2.08	0.83	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	25.86	13.49	17.99	13.49	10.12	2.25	2.25	2.25	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	1.90	3.81	1.90	1.90	0.00	0.32	0.00	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.09	3.34	1.67	1.67	0.42	0.42	0.42	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	18.80	6.27	5.22	6.27	4.76	1.16	3.13	0.58	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	20.59	5.91	3.88	3.88	3.04	0.34	3.04	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	21.39	8.42	3.64	5.23	3.19	1.14	3.41	0.00	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	21.42	6.34	5.14	6.56	3.94	1.42	2.84	0.11	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	21.06	9.03	4.08	4.51	3.01	1.07	2.58	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	27.34	8.83	2.80	4.52	2.15	2.15	2.15	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	23.29	8.47	3.86	6.73	3.11	0.37	2.86	0.37	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	19.21	8.06	3.43	5.15	3.60	1.03	1.89	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	14.74	7.05	3.52	4.81	2.24	0.32	2.24	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	22.38	11.75	14.55	3.92	3.92	1.68	0.56	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	28.13	15.15	14.28	8.22	5.63	4.33	1.30	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	34.37	0.00	10.58	7.93	2.64	2.64	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	26.10	13.05	7.41	7.76	5.64	2.12	0.71	1.41	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	31.97	13.08	3.63	7.27	6.54	3.63	2.18	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	27.10	10.32	7.52	11.19	6.47	2.10	2.45	0.70	0.70
Hepatocyte, donor1	11523-119I2	52.06	16.95	10.90	37.53	9.68	1.21	13.32	1.21	2.42
Hepatocyte, donor2	11603-120I1	44.17	11.85	6.46	5.39	9.70	0.00	6.46	0.00	0.00
Hepatocyte, donor3	11684-122I1	33.13	14.11	11.66	12.27	9.82	1.84	2.45	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	43.08	20.23	2.61	0.65	0.65	7.83	0.00	3.26	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	58.38	14.33	5.42	10.14	3.85	1.57	0.35	0.17	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	15.09	5.21	8.10	3.57	3.29	1.65	2.20	0.41	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	12.74	3.18	15.92	3.18	0.00	0.00	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	33.38	0.00	6.68	0.00	6.68	6.68	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	27.08	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	34.61	18.00	12.46	2.77	2.77	5.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	25.03	7.51	7.51	2.50	5.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	35.60	11.87	0.00	11.87	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	25.63	23.07	7.69	7.69	5.13	7.69	0.00	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	13.71	0.00	4.57	4.57	22.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	35.74	29.24	8.12	9.75	3.25	8.12	1.62	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	28.34	16.67	13.34	3.33	1.67	5.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	61.72	21.78	10.89	0.00	0.00	0.00	0.00	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	22.50	30.44	6.62	10.59	3.97	3.97	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	28.82	17.74	6.65	7.76	3.33	3.33	1.11	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	52.38	10.48	5.24	0.00	10.48	5.24	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	27.71	21.42	6.93	5.04	5.04	3.78	0.63	3.15	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	32.48	21.65	9.28	4.64	7.73	7.73	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	30.36	17.44	10.98	10.98	6.46	5.81	0.00	1.94	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	32.20	19.32	9.66	6.44	0.00	4.83	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	36.67	24.45	12.22	6.52	7.33	4.07	1.63	2.44	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	32.75	25.19	10.50	7.98	3.78	5.04	3.78	2.10	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	30.54	18.48	7.23	7.23	4.82	1.61	0.80	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	24.01	12.93	6.46	5.54	1.85	5.54	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	45.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	24.55	22.66	8.97	4.25	8.97	5.19	1.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	22.67	14.51	4.53	6.35	4.53	2.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	31.21	15.07	5.38	4.30	8.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	15.25	17.79	1.27	5.08	1.27	3.81	1.27	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	17.86	22.96	8.29	8.93	3.19	5.74	0.64	1.28	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	32.81	21.87	3.65	9.11	3.65	1.82	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	17.85	25.71	10.00	6.43	3.57	4.28	0.00	2.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	33.18	0.00	6.64	0.00	9.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	21.91	14.82	5.56	4.32	4.94	3.40	0.31	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	22.83	1.76	8.78	0.00	5.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	31.43	15.72	6.29	6.29	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	23.64	19.47	5.56	2.78	2.78	4.17	0.70	1.39	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	28.77	30.98	8.85	2.21	6.64	8.85	0.00	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	19.45	16.21	3.24	9.73	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	25.29	32.26	6.98	4.36	7.85	5.23	2.62	4.36	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	22.50	13.50	2.25	0.00	2.25	2.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	20.91	3.48	6.97	0.00	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	29.87	37.34	13.87	2.13	5.33	9.60	1.07	4.27	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	23.55	19.40	13.85	8.31	0.00	5.54	0.00	5.54	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	5.70	14.25	5.70	5.70	5.70	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.93	20.25	11.97	5.52	1.84	4.60	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	48.41	36.30	0.00	3.03	3.03	15.13	0.00	9.08	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	49.67	6.21	6.21	0.00	18.63	0.00	18.63	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	47.58	29.61	5.29	1.06	3.17	10.57	0.00	4.23	1.06
Keratinocyte - epidermal, donor1	11272-116H3	11.75	7.92	5.96	5.71	2.69	0.49	0.49	0.49	0.33
Keratinocyte - epidermal, donor2	11349-117G8	30.45	18.74	7.61	5.27	5.27	1.17	0.00	1.17	1.76
Keratinocyte - epidermal, donor3	11421-118F8	33.70	8.05	9.18	12.40	10.70	1.04	2.84	0.38	0.76
Keratinocyte - oral, donor1	11251-116E9	18.73	3.18	6.36	4.65	4.65	1.36	0.91	0.91	0.11
Keratocytes, donor1	11527-119I6	31.29	16.50	10.31	3.78	4.81	4.13	1.38	0.34	0.69
Keratocytes, donor2	11607-120I5	18.75	9.37	5.86	10.55	2.34	1.17	2.34	1.17	0.00
Keratocytes, donor3	11688-122I5	9.09	6.32	4.15	1.78	1.38	2.77	0.20	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	39.56	8.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	15.10	6.47	7.55	7.55	7.55	1.08	5.39	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	23.99	6.00	8.19	5.54	4.84	4.38	0.69	0.35	0.46
Lens Epithelial Cells, donor3	11690-122I7	11.91	4.14	6.05	4.44	4.54	1.92	0.71	0.71	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	28.46	8.89	7.83	4.15	4.27	1.90	1.07	0.83	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	28.74	7.26	3.91	4.74	4.47	1.67	0.84	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	26.92	7.24	7.08	4.88	5.51	2.05	0.47	0.79	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	20.97	6.45	6.99	4.84	6.45	2.69	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	22.06	6.30	8.19	4.73	5.36	1.58	0.00	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	29.00	10.03	10.03	5.18	5.71	1.83	0.65	0.22	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	20.11	9.44	6.57	5.75	2.46	1.23	0.82	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	24.78	8.60	8.60	5.81	6.32	1.77	1.26	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	25.62	10.42	9.15	5.63	4.79	0.84	0.99	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	17.01	4.35	5.93	4.75	3.16	0.79	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	21.52	7.76	7.95	3.88	6.20	1.94	0.97	0.58	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	24.81	7.59	8.33	6.67	5.92	2.22	1.30	0.93	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.86	7.67	5.57	4.18	3.14	2.09	0.35	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	30.05	7.87	8.11	5.72	5.01	3.34	0.72	0.72	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	22.39	7.42	9.48	5.22	4.67	1.37	0.82	0.82	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.01	5.85	5.24	4.31	2.46	1.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	29.30	7.17	6.86	5.30	4.68	0.62	0.94	0.62	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	30.38	11.16	8.23	6.40	5.12	2.01	0.91	0.91	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	19.42	6.25	7.90	5.59	4.28	1.97	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	24.02	5.86	6.15	4.98	5.27	2.05	0.29	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	25.64	8.96	6.72	5.48	4.23	1.74	0.25	1.00	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.88	4.85	7.27	2.91	2.42	2.42	0.48	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	19.66	4.85	6.46	3.50	4.04	1.35	0.81	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	20.44	5.90	8.93	3.63	6.06	1.97	0.30	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	19.18	5.18	5.18	5.70	1.56	2.07	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	20.31	5.65	5.86	4.19	2.93	2.72	0.42	0.21	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	20.90	7.67	6.92	3.91	4.06	1.65	0.60	1.05	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	24.76	6.88	6.19	2.06	4.82	2.06	0.00	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.99	8.09	6.96	5.08	3.95	2.26	0.38	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	21.31	6.68	9.44	4.77	5.62	1.06	0.74	0.32	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	21.81	6.78	3.88	3.88	2.91	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	18.19	3.97	7.94	5.95	2.98	0.33	0.00	1.65	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	21.43	7.56	9.79	6.07	5.58	1.61	0.87	0.50	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	24.06	7.03	9.26	5.92	5.55	0.74	1.85	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	18.04	3.95	9.88	2.96	3.46	0.99	0.25	0.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	24.75	7.70	7.56	5.36	4.12	2.61	0.55	0.82	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	24.77	6.43	3.54	5.47	2.25	0.64	1.29	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	17.96	5.17	3.65	3.96	3.04	1.52	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	22.81	6.44	7.70	4.20	4.34	1.82	0.98	0.98	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	21.69	6.40	8.89	4.62	3.20	0.71	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	17.94	4.85	9.21	5.82	3.39	1.94	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	27.70	8.71	9.65	5.60	6.54	1.87	1.09	0.47	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	18.98	7.52	7.16	6.45	3.22	3.58	0.00	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.33	6.21	3.92	3.59	3.92	2.29	0.33	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	23.78	10.83	8.00	7.06	5.89	2.12	1.18	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	27.72	10.15	6.93	5.57	4.83	1.86	0.74	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	16.90	4.87	7.94	4.35	3.07	1.02	0.26	1.28	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	23.27	7.76	4.48	4.48	5.37	1.49	0.00	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	40.79	20.39	11.33	9.06	0.00	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	47.56	15.34	9.97	7.67	11.51	3.07	4.60	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	46.76	20.04	11.13	7.42	7.42	5.20	1.48	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	61.35	22.00	11.42	11.85	9.73	3.81	2.54	1.69	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	61.19	21.10	17.58	11.25	10.55	4.92	1.41	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	55.10	22.42	9.34	7.47	7.47	2.80	1.87	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	40.19	22.67	6.70	11.34	6.18	0.52	0.52	1.55	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	49.96	14.27	11.89	4.76	5.95	3.57	1.19	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	80.75	28.27	14.25	8.37	7.69	3.39	2.71	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	41.88	16.00	11.92	8.14	5.23	3.20	0.29	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	44.57	13.06	8.55	5.40	4.50	1.80	2.25	1.35	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	77.50	21.68	14.36	9.08	7.59	3.12	3.39	1.08	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	57.00	27.22	12.32	9.24	6.68	2.57	2.05	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	38.81	16.23	10.94	4.23	6.70	3.18	1.41	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	49.97	11.33	8.66	9.33	4.00	4.00	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	52.47	17.83	9.17	11.21	4.08	2.04	3.57	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	45.09	20.54	11.47	6.14	6.67	3.20	3.47	0.00	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	52.15	16.82	7.56	5.67	3.97	2.27	1.32	0.76	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	53.99	12.27	12.88	11.04	1.84	3.07	0.61	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	52.19	20.39	7.34	4.89	10.60	0.82	4.89	0.82	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	43.11	11.25	8.54	9.16	4.37	2.50	0.83	1.04	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	48.77	12.89	8.97	9.53	3.08	0.84	0.84	1.12	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	60.79	23.70	8.24	5.15	4.12	2.06	5.15	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	47.90	14.22	9.00	9.58	4.35	2.32	2.03	0.87	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	43.34	13.15	6.28	10.76	3.29	1.20	1.49	1.20	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	43.71	11.62	7.19	5.53	4.98	2.21	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	63.63	17.67	14.49	9.90	6.36	2.83	1.77	0.71	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	59.74	14.75	8.85	9.96	2.21	1.48	2.21	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	39.14	14.97	9.21	6.91	5.76	2.30	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	58.33	21.11	10.36	6.14	7.29	1.92	2.69	2.69	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	59.44	21.51	6.79	7.36	5.10	1.13	4.53	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	44.31	17.23	13.13	8.20	8.20	1.64	1.64	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	63.72	16.72	11.30	8.59	3.62	5.42	4.07	1.36	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	43.09	15.08	10.77	6.46	2.15	2.15	0.72	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	54.52	24.65	11.95	7.47	9.71	4.48	3.73	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	59.45	22.30	9.66	7.43	2.60	1.49	1.49	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	46.09	18.09	7.75	7.75	4.31	1.72	3.02	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	67.65	17.98	5.99	6.85	11.13	1.71	1.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	61.30	18.66	13.66	7.33	5.33	4.66	4.66	1.33	2.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	39.82	21.12	6.64	9.05	4.83	4.22	1.21	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	44.79	31.99	12.09	6.40	5.69	2.13	2.84	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	43.65	18.90	14.44	9.97	6.53	2.75	2.75	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	52.60	16.10	9.66	6.98	6.44	2.15	1.61	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	47.14	19.53	11.45	11.45	12.12	2.69	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	61.12	20.37	12.22	8.15	4.82	4.07	2.22	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	70.94	10.47	9.30	6.98	1.16	1.16	4.65	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	42.31	17.98	17.98	10.58	8.46	1.06	1.06	0.00	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	61.62	20.01	11.20	7.60	6.00	2.00	3.20	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	56.70	31.26	5.81	9.45	8.00	6.54	5.81	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	69.75	19.93	19.16	12.26	10.73	3.07	2.30	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	73.01	19.73	9.37	14.80	5.92	3.45	2.96	0.00	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	52.69	16.00	8.47	10.35	2.82	3.76	1.88	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	72.41	18.60	20.11	9.55	11.56	5.53	6.54	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	54.07	18.93	9.46	11.72	8.56	5.86	3.60	2.25	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	48.19	12.05	8.61	8.61	1.72	6.88	1.72	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	51.21	20.49	9.35	12.47	5.34	5.34	4.01	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	60.61	20.72	11.34	7.82	3.91	1.17	2.35	1.96	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	44.20	16.49	10.56	7.92	5.28	3.30	3.30	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	51.37	18.68	12.45	9.34	12.97	4.15	1.04	0.52	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	59.95	15.31	10.06	8.75	7.00	4.38	2.63	0.44	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	35.22	13.98	8.39	6.71	5.03	1.12	3.91	1.12	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	49.02	17.67	11.04	5.74	3.97	2.21	2.65	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	52.07	17.74	11.57	7.33	6.56	4.63	1.93	1.16	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	46.58	12.15	9.11	8.10	3.54	0.51	1.01	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	50.95	16.82	11.05	8.17	7.21	1.92	2.88	0.96	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	60.03	16.70	11.13	9.54	5.57	3.18	1.59	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	40.71	11.54	14.58	4.86	0.00	1.22	1.22	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	33.89	11.07	6.23	6.23	7.61	2.77	1.38	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	63.08	21.66	15.20	9.12	5.70	4.18	1.52	0.76	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	52.16	21.17	11.36	4.13	2.07	0.52	1.03	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	37.49	13.91	11.49	4.84	4.23	3.63	4.84	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	52.61	13.63	11.09	7.92	6.97	2.85	2.22	1.27	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	54.91	17.59	10.13	5.33	1.60	1.60	4.26	1.60	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	37.93	18.39	9.77	7.47	5.17	3.45	2.87	0.57	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	62.74	15.94	8.74	6.69	8.74	3.60	2.06	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	55.88	14.85	8.49	9.90	8.49	3.54	0.71	2.83	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	39.16	18.73	5.67	8.51	4.54	1.13	2.84	1.70	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	60.74	17.89	7.07	8.74	8.32	1.66	2.50	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	57.16	14.88	10.96	6.26	9.40	0.78	1.57	2.35	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	38.83	15.03	12.11	7.93	5.43	4.18	2.09	2.51	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	62.73	15.80	13.94	8.83	7.90	3.25	1.39	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	53.52	18.06	11.37	6.69	7.36	0.67	0.67	2.01	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	44.91	18.18	10.69	11.76	6.42	3.74	2.67	0.53	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	63.85	15.76	10.10	8.08	6.47	2.42	2.83	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	45.89	18.36	4.59	7.34	3.67	1.84	2.75	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	37.34	24.01	10.67	5.33	4.45	3.56	1.78	0.89	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	64.40	11.40	6.84	7.98	6.27	1.14	3.42	1.14	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	49.08	15.34	4.60	7.67	3.07	3.07	5.37	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	41.04	17.51	11.49	10.94	7.11	4.38	4.38	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	70.38	16.93	7.57	8.46	5.35	1.34	2.67	1.34	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	81.37	19.50	8.84	8.06	6.50	2.60	4.94	1.04	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	45.09	21.88	8.62	9.28	9.28	0.66	6.63	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	85.22	10.39	12.47	6.24	2.08	2.08	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	13.45	14.36	4.33	2.73	2.73	0.91	0.23	1.37	0.23
Macrophage - monocyte derived, donor2	11313-117C8	13.21	8.44	2.57	1.84	2.57	0.73	0.73	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	15.99	12.32	5.64	2.75	4.06	2.23	0.13	0.66	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	24.43	9.56	4.78	7.97	4.78	2.12	0.53	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	37.08	12.36	9.51	11.57	4.12	0.95	2.85	0.79	1.43
Mallassez-derived cells, donor3	11930-125I4	22.38	5.70	6.25	3.61	3.20	0.56	1.25	0.14	0.28
Mammary Epithelial Cell, donor1	11273-116H4	19.23	14.75	6.48	5.38	4.38	2.99	1.59	0.80	0.70
Mammary Epithelial Cell, donor2	11350-117G9	22.30	9.84	5.21	4.92	1.74	0.87	1.74	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	18.21	6.49	6.49	6.73	5.99	0.50	1.50	0.75	0.25
Mast cell - stimulated, donor1	11487-119E2	82.71	2.71	14.24	10.17	8.14	2.71	13.56	0.68	0.00
Mast cell, donor1	11563-120D6	40.01	19.79	11.46	6.38	6.38	2.60	0.87	0.54	0.76
Mast cell, donor2	11565-120D8	21.10	14.86	10.40	5.65	3.57	1.78	0.30	0.89	0.30
Mast cell, donor3	11566-120D9	13.73	14.63	4.05	4.28	1.80	3.83	0.00	0.68	0.00
Mast cell, donor4	11567-120E1	16.31	19.86	9.40	6.56	6.56	2.48	0.00	1.24	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	39.81	21.18	12.31	5.66	5.43	2.00	1.11	0.44	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	65.37	42.61	23.93	25.10	6.42	1.75	5.84	1.17	1.17
Mast cell, expanded, donor5	11939-126A4	67.23	42.91	17.09	10.44	10.10	5.51	1.15	2.18	0.57
Mast cell, expanded, donor8	11941-126A6	52.89	27.45	15.23	11.21	10.38	2.18	1.84	0.67	0.50
Melanocyte - dark, donor1	11502-119F8	38.51	11.04	12.44	8.36	9.85	1.29	1.99	0.20	0.80
Melanocyte - dark, donor2	11582-120F7	13.84	3.11	6.58	2.77	3.81	1.04	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	32.74	11.30	9.92	9.06	6.88	1.81	2.39	0.14	0.51
Melanocyte - light, donor1	11274-116H5	20.69	9.64	10.34	6.58	5.88	0.94	0.71	0.24	0.71
Melanocyte - light, donor2	11351-117H1	22.52	14.33	6.82	16.38	6.14	1.36	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	19.08	12.14	10.41	3.47	5.20	1.73	0.87	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	39.57	11.04	7.29	5.31	7.81	2.19	1.15	0.62	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	20.44	7.26	7.53	9.14	4.57	1.61	1.61	0.54	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	19.55	11.52	8.57	8.04	5.62	1.87	0.80	0.00	1.07
Meningeal Cells, donor1	11493-119E8	21.21	11.04	18.11	7.07	6.82	2.11	1.86	0.37	0.50
Meningeal Cells, donor2	11573-120E7	16.73	9.68	10.12	8.80	4.84	2.20	0.88	0.88	1.32
Meningeal Cells, donor3	11654-122E7	29.10	10.11	10.02	8.80	5.38	2.04	2.04	0.82	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	12.26	4.85	6.84	1.14	2.57	0.86	0.86	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	13.69	7.14	7.35	7.14	3.42	1.21	0.60	0.00	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	11.83	10.51	5.26	9.20	5.26	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	20.93	7.85	6.54	3.92	3.92	0.00	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	7.18	9.33	5.74	3.59	0.72	0.72	2.15	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	7.20	5.93	3.81	2.33	2.54	0.64	0.42	0.42	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	4.02	9.05	4.52	2.01	1.01	1.01	0.50	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	18.02	7.69	7.69	5.49	5.27	2.42	2.42	0.66	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	11.69	7.31	3.65	7.31	3.65	2.19	1.46	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	16.78	6.14	6.75	4.50	4.09	1.64	2.25	0.82	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	3.60	3.46	4.71	2.22	0.83	1.80	0.28	0.42	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	13.01	13.75	5.95	5.58	3.35	0.74	0.74	0.37	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	17.63	7.89	6.84	5.00	2.89	1.18	0.13	0.13	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.90	8.90	6.53	2.97	2.08	0.00	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	39.70	14.01	7.01	7.01	4.67	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	23.69	11.53	10.25	8.97	8.33	1.28	1.28	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	13.82	11.70	7.09	3.54	3.90	1.77	3.90	0.71	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	11.57	7.82	3.44	3.13	3.44	0.63	0.00	0.31	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	22.50	5.08	5.81	10.16	2.18	1.45	2.90	0.00	1.45
Mesothelial Cells, donor1	11247-116E5	9.55	6.36	3.71	2.12	2.92	0.27	0.27	0.00	0.53
Mesothelial Cells, donor2	12156-128G5	13.01	7.01	5.51	2.00	2.00	0.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	11.06	7.01	4.26	2.96	2.75	0.87	0.65	0.36	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	6.75	8.10	5.40	0.00	1.35	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	11.08	10.59	5.42	3.20	3.45	1.97	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.83	9.42	4.42	2.36	3.24	1.18	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	10.37	3.46	0.00	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	7.44	8.06	4.34	2.48	2.48	1.55	0.00	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.16	7.88	3.32	1.04	2.90	1.45	0.00	0.83	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	2.32	0.00	6.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	9.26	10.51	4.50	2.75	2.25	2.25	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	7.91	11.17	2.79	0.47	2.33	0.93	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	8.13	8.33	3.25	1.42	2.44	1.83	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.50	9.90	1.19	3.96	1.98	0.00	0.00	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	34.21	0.00	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	9.73	4.42	6.19	1.77	2.65	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	12.54	8.74	7.22	1.14	2.28	1.90	0.00	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	7.90	3.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	12.52	8.49	5.73	2.12	3.40	1.49	0.00	0.85	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	3.68	4.60	0.92	0.00	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	8.05	6.86	3.87	2.68	1.79	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	6.71	0.00	0.00	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	9.28	7.03	3.01	1.76	2.26	1.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.52	4.75	1.43	2.14	0.71	1.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.98	2.21	1.66	0.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.98	5.30	2.07	1.38	2.07	0.46	0.00	0.46	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.05	5.68	2.10	0.84	0.84	0.63	0.00	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	13.86	5.50	2.65	4.08	3.06	1.22	0.41	0.41	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	11.16	6.01	3.22	2.79	1.07	1.50	0.00	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	3.56	6.22	1.33	0.67	1.11	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.57	3.50	1.75	0.88	0.88	1.53	0.00	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.06	4.06	1.52	1.01	0.00	0.51	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	1.66	0.00	3.31	1.66	0.00	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.44	3.26	2.99	1.36	0.54	0.27	0.00	0.00	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.41	2.94	0.88	1.18	2.06	0.29	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	3.27	3.27	0.00	2.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.13	2.40	0.96	2.40	1.92	1.44	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.00	2.80	2.40	1.20	0.00	0.40	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	2.74	1.37	0.00	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	8.01	5.01	3.50	1.50	1.50	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	2.04	0.00	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.01	5.69	1.31	1.75	1.31	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	4.41	1.10	1.10	0.00	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.12	1.28	0.64	1.92	0.64	0.00	0.00	0.64	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.69	3.72	1.74	3.22	0.74	0.99	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.09	1.39	2.78	0.70	0.00	0.70	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	4.42	0.00	4.42	2.21	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	8.55	4.79	1.03	0.68	1.03	0.68	0.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.50	2.63	0.88	1.31	0.88	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.20	2.49	1.07	0.71	0.36	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	6.73	3.37	1.96	1.12	1.40	0.00	1.12	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.08	2.91	1.25	0.42	0.83	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.91	1.75	1.75	0.58	0.58	0.00	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	4.83	4.22	4.22	1.51	0.90	0.30	0.00	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.60	3.76	1.67	1.25	2.09	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	7.39	2.77	0.92	3.69	0.00	1.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.83	5.12	4.55	2.28	3.98	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.97	3.45	2.76	2.63	2.35	0.28	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	9.33	3.37	2.07	1.55	1.81	1.04	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	5.15	3.86	1.29	2.14	2.14	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.18	1.91	0.64	0.64	2.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	3.74	1.87	2.14	0.53	1.33	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	5.69	6.29	2.69	0.90	1.20	0.90	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	4.80	3.11	1.98	2.26	2.68	0.14	0.28	0.42	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	5.41	3.19	1.27	1.27	1.27	0.64	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	5.97	4.86	2.21	1.55	2.65	0.66	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	6.83	3.79	1.14	0.76	0.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	5.40	3.41	1.14	1.42	1.14	0.57	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	8.36	5.16	1.72	1.97	0.98	0.49	0.25	0.74	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	4.56	3.26	3.26	0.65	0.65	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	2.65	3.82	1.18	1.47	1.18	0.00	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	7.21	4.90	1.44	1.73	1.44	0.86	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	4.12	6.59	3.71	0.41	1.65	0.41	0.41	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.06	3.28	0.60	1.19	0.60	1.49	0.60	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	11.30	3.77	7.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	5.35	0.00	1.78	0.00	0.00	0.00	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	14.46	12.81	3.94	4.93	3.61	1.64	0.00	0.00	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	18.94	6.31	5.26	3.16	7.36	2.10	2.10	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	12.06	13.44	2.97	2.37	2.57	1.38	0.00	0.59	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	10.24	4.66	1.86	0.93	0.93	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	9.39	7.89	4.88	3.00	3.00	1.13	0.00	1.13	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	17.84	15.71	4.26	3.73	4.26	1.86	0.53	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.48	11.31	3.62	3.28	3.28	1.81	0.00	0.34	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	9.58	11.79	2.21	3.68	1.47	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	14.29	14.66	3.30	4.76	4.40	1.83	0.73	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	15.56	6.22	3.11	3.11	1.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	17.64	8.55	8.55	3.21	1.07	4.81	0.53	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	7.73	0.00	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	15.15	14.14	3.03	5.05	4.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	18.13	8.43	5.06	4.22	2.11	1.69	0.00	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	25.88	5.45	8.17	6.81	4.09	1.36	1.36	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	15.26	5.72	2.54	3.18	3.18	3.18	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	20.25	6.48	0.81	3.24	2.43	0.81	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	24.17	9.06	6.04	1.51	1.51	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	74.23	39.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	16.31	6.52	3.26	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	9.26	9.05	4.52	5.60	4.31	1.72	1.29	0.65	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	9.41	5.23	5.75	4.70	1.57	2.09	1.05	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	12.68	3.34	6.67	4.67	4.00	0.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	9.18	7.10	5.43	2.09	2.92	2.92	0.00	0.83	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	8.56	3.23	2.66	1.71	0.19	1.33	0.95	0.57	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	12.77	4.79	4.79	3.19	3.19	3.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	5.44	6.12	1.36	4.76	2.72	2.04	0.00	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1.84	1.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.95	2.09	4.60	2.93	2.09	4.19	0.42	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	11.16	3.95	3.72	1.86	2.56	1.86	0.46	1.16	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.81	3.51	5.67	4.05	2.97	1.08	0.27	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	11.98	6.52	3.99	3.99	2.31	1.68	0.42	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	10.92	6.45	3.97	1.99	1.49	2.48	0.00	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.04	2.71	1.08	1.89	1.35	1.08	0.00	0.54	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.12	3.17	1.81	1.59	2.95	1.13	0.68	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.21	4.25	2.45	2.29	1.80	1.63	0.65	0.65	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	6.01	3.46	1.64	2.19	1.64	0.73	0.18	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.96	3.71	2.65	2.12	1.59	1.59	0.00	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	3.00	1.80	3.00	2.40	0.60	1.80	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	2.95	2.30	0.66	0.33	0.00	1.64	0.66	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.72	1.95	1.63	1.63	3.25	1.30	0.16	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	7.41	3.00	3.35	2.29	0.71	2.12	0.00	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.92	4.92	2.81	1.41	2.81	1.41	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.52	2.30	0.92	0.92	0.92	2.30	0.00	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	7.07	3.53	3.53	2.89	1.61	0.96	0.32	0.32	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	3.79	2.07	0.69	0.00	0.34	0.34	0.34	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	5.06	2.53	5.06	5.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	5.12	5.35	2.45	1.78	3.12	0.89	0.45	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.89	3.39	0.85	0.85	0.85	1.69	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	7.12	2.37	0.95	1.19	0.95	0.47	0.00	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	8.58	3.86	2.58	2.15	2.15	3.00	0.86	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6.00	5.33	2.67	2.00	1.00	2.33	0.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.02	3.61	4.51	0.45	1.35	0.90	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.33	3.57	1.59	3.57	0.40	1.19	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	10.22	4.64	2.79	1.86	0.00	3.71	0.00	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	6.05	1.89	1.51	0.00	0.76	1.51	0.00	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.45	2.61	3.91	3.26	2.93	1.30	0.98	0.65	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.54	1.31	1.74	3.49	1.74	1.74	0.00	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	2.71	2.71	3.17	2.26	0.90	0.90	0.00	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	4.41	2.65	0.88	0.88	0.88	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.98	3.32	1.99	1.99	0.66	0.66	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.42	0.99	2.48	1.98	1.98	2.48	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	10.72	3.45	2.68	2.30	1.15	2.68	0.00	0.77	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	5.75	3.33	1.81	0.60	1.21	0.30	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	8.84	4.42	1.55	3.98	0.22	2.87	0.44	0.88	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.74	2.03	2.03	1.36	0.68	3.39	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	10.22	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.80	2.44	4.88	0.00	1.83	4.27	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	8.81	4.09	3.78	3.46	1.89	0.63	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.75	4.24	1.51	0.61	1.51	1.82	0.61	1.21	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	8.70	3.16	0.79	2.37	1.58	1.58	0.00	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	9.07	1.13	1.13	2.27	0.00	0.00	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	12.05	3.85	2.98	4.84	2.11	1.74	0.99	0.75	0.12
Myoblast, donor2	11322-117D8	7.48	5.95	4.03	4.03	2.49	1.34	0.00	0.19	0.19
Myoblast, donor3	11398-118D3	9.42	7.74	3.87	3.36	2.19	1.01	1.01	0.84	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	84.79	15.18	3.06	3.21	2.77	7.00	0.00	1.61	0.88
Natural Killer Cells, donor1	11230-116C6	13.84	17.84	3.69	5.54	1.54	0.62	0.00	0.62	1.23
Natural Killer Cells, donor2	11311-117C6	12.36	17.79	1.51	5.43	2.71	3.02	0.00	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	20.25	19.14	4.42	7.18	4.05	4.05	0.18	0.18	0.92
Neural stem cells, donor1	11275-116H6	19.60	13.43	6.53	8.35	3.63	3.27	1.81	1.81	0.73
Neural stem cells, donor2	11352-117H2	15.41	11.55	5.78	0.00	3.85	3.85	1.93	1.93	0.00
Neurons, donor1	11494-119E9	25.03	15.93	5.69	11.38	1.14	12.52	0.00	2.28	1.14
Neurons, donor2	11574-120E8	13.21	14.09	3.96	3.52	2.64	2.64	0.88	1.10	0.22
Neurons, donor3	11655-122E8	20.55	12.33	1.64	1.64	2.47	2.47	0.00	1.64	1.64
Neutrophils, donor1	11233-116C9	10.21	2.78	0.93	0.93	0.93	12.06	0.00	1.86	0.00
Neutrophils, donor2	11314-117C9	17.39	2.90	5.80	2.90	0.00	0.00	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	11.00	3.05	0.61	1.83	0.61	4.28	0.00	1.83	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	6.77	2.61	2.14	2.49	1.31	1.66	0.59	0.12	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	6.51	2.60	6.19	3.91	3.91	1.30	1.30	2.28	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	3.81	4.41	4.01	1.80	2.61	2.41	0.00	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	3.58	3.99	3.58	1.79	1.51	0.41	0.14	0.00	0.28
Olfactory epithelial cells, donor2	11934-125I8	8.11	5.36	4.20	2.03	3.04	1.30	0.58	0.43	0.14
Olfactory epithelial cells, donor3	11935-125I9	5.45	3.52	3.41	2.61	2.27	0.79	0.23	0.57	0.11
Olfactory epithelial cells, donor4	11936-126A1	10.62	5.16	5.06	5.06	4.58	1.27	0.58	0.68	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	43.33	13.24	12.64	6.02	7.82	1.20	1.81	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	4.47	6.38	3.40	2.98	0.64	1.49	0.00	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	5.72	5.72	1.14	1.14	4.57	1.14	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	27.93	16.14	18.62	17.38	7.45	0.62	1.86	1.24	1.24
Osteoblast, donor1	11277-116H8	22.67	8.79	10.55	12.51	6.84	3.71	1.95	0.59	0.78
Osteoblast, donor2	11354-117H4	22.47	5.62	4.21	7.02	5.62	1.40	2.11	0.70	0.70
Osteoblast, donor3	11426-118G4	15.28	9.24	8.35	5.33	4.80	1.96	0.71	0.53	0.71
Pancreatic stromal cells, donor1	11249-116E7	12.89	7.75	5.64	3.37	4.30	1.52	1.85	0.84	0.34
Pericytes, donor1	11491-119E6	10.79	7.45	8.79	4.45	4.34	4.45	0.22	0.56	0.00
Pericytes, donor2	11571-120E5	14.94	12.68	10.41	5.66	4.30	3.85	1.36	2.04	0.68
Pericytes, donor3	11652-122E5	18.72	8.54	9.97	5.90	5.49	3.46	1.83	0.61	0.61
Perineurial Cells, donor1	11499-119F5	24.64	8.02	9.61	4.29	5.43	2.49	1.36	0.57	0.45
Perineurial Cells, donor2	11579-120F4	15.64	4.05	6.72	4.78	5.52	1.01	0.74	0.37	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	12.11	10.84	3.19	4.14	1.59	2.87	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	6.61	4.41	1.47	2.20	1.96	2.69	0.00	0.73	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	16.69	15.14	2.46	3.49	3.36	3.24	0.00	0.26	0.52
Placental Epithelial Cells, donor1	11278-116H9	46.88	15.07	4.30	8.13	5.26	2.39	0.00	1.67	0.96
Placental Epithelial Cells, donor2	11355-117H5	17.74	9.98	5.54	9.98	2.22	1.11	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	24.34	9.23	6.48	8.64	6.09	2.55	0.79	1.18	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	25.00	12.03	9.18	6.01	8.86	1.90	0.63	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	6.19	10.13	6.19	6.00	2.25	1.50	0.56	0.38	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	6.92	10.44	3.52	3.00	2.74	0.52	0.52	0.78	0.00
Preadipocyte - breast, donor2	11328-117E5	10.36	11.26	8.11	4.50	5.63	3.38	0.45	0.45	0.23
Preadipocyte - omental, donor1	11468-119C1	7.89	7.89	5.01	4.26	2.77	0.75	0.75	0.32	0.43
Preadipocyte - omental, donor2	11329-117E6	10.04	9.17	7.86	2.62	5.67	1.31	1.31	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	24.64	11.60	7.31	8.59	9.31	1.86	2.58	0.29	0.72
Preadipocyte - perirenal, donor1	11469-119C2	5.91	5.91	6.89	6.89	3.94	2.95	0.98	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	19.04	7.68	9.83	8.29	8.29	1.84	3.38	0.61	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	20.36	9.56	12.40	6.20	8.50	3.54	4.25	1.06	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	14.47	8.68	11.24	6.98	5.62	1.87	2.04	0.00	0.51
Preadipocyte - visceral, donor1	11280-116I2	10.62	6.33	6.80	5.59	5.50	2.33	3.17	0.84	0.19
Preadipocyte - visceral, donor2	11357-117H7	21.63	12.89	10.58	9.20	4.14	0.92	3.68	0.00	1.38
Preadipocyte - visceral, donor3	11429-118G7	7.00	5.96	5.85	3.55	3.55	0.94	1.15	0.63	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	109.22	14.33	6.79	13.88	4.53	2.87	0.15	0.45	1.66
Prostate Epithelial Cells, donor2	11331-117E8	21.40	10.16	5.55	5.96	5.01	0.54	2.57	0.68	0.95
Prostate Epithelial Cells, donor3	11404-118D9	45.81	8.57	7.84	4.90	5.57	1.96	0.98	0.86	0.98
Prostate Stromal Cells, donor1	11254-116F3	13.21	8.20	4.90	4.44	2.85	0.80	0.68	0.46	0.68
Prostate Stromal Cells, donor2	11332-117E9	22.05	9.86	9.32	7.17	4.12	1.26	0.90	0.72	0.72
Prostate Stromal Cells, donor3	11405-118E1	10.32	5.94	6.05	3.44	3.86	1.56	0.10	0.21	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	119.71	18.98	16.42	13.87	12.41	3.28	6.57	0.73	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	110.83	10.40	10.95	11.02	6.03	2.63	5.61	1.11	0.69
Renal Epithelial Cells, donor1	11517-119H5	164.34	28.40	33.98	21.30	19.27	6.09	16.23	2.03	1.52
Renal Epithelial Cells, donor2	11597-120H4	109.54	16.36	15.65	19.92	13.52	2.85	8.54	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	137.41	15.35	14.40	18.42	8.15	2.43	12.28	1.06	0.95
Renal Glomerular Endothelial Cells, donor1	11514-119H2	40.17	12.26	14.30	5.45	9.53	2.04	2.04	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	26.28	10.78	13.61	4.99	8.09	2.43	0.94	0.54	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	49.29	12.88	12.65	9.32	9.32	1.11	2.89	0.44	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	129.10	33.27	29.28	14.64	9.98	6.65	4.66	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	82.53	18.27	21.13	18.05	14.75	3.08	6.16	1.76	1.54
Renal Mesangial Cells, donor2	11598-120H5	132.92	16.93	21.94	21.32	9.40	3.13	8.78	0.63	1.25
Renal Mesangial Cells, donor3	11679-122H5	119.29	15.81	20.81	15.81	9.43	2.22	5.55	2.22	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	60.40	13.69	18.25	8.05	9.13	1.61	3.49	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	52.29	7.17	13.49	5.48	5.06	0.42	2.53	0.42	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	71.93	12.92	18.90	14.27	10.80	3.47	5.40	1.35	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	26.45	4.93	5.96	3.63	3.89	3.11	0.26	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	14.78	7.67	5.68	4.83	3.70	2.27	0.57	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	22.64	5.15	10.29	3.09	3.09	3.09	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	12.29	8.03	2.76	4.27	0.25	4.52	0.50	0.75	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	55.59	22.45	8.42	11.49	6.28	2.54	2.14	0.94	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	5.36	5.36	0.89	0.00	0.00	2.68	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	7.15	3.30	1.10	0.55	0.55	0.55	0.00	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	8.12	6.96	1.16	1.16	0.00	0.58	1.16	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	6.50	6.37	2.34	0.91	1.30	0.26	0.52	0.39	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	11.02	5.46	2.88	2.58	1.49	1.19	0.60	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	12.49	7.47	2.68	4.13	2.23	1.23	0.67	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	9.06	7.19	2.98	1.98	2.23	0.74	0.74	0.37	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	12.47	6.64	4.43	3.15	2.68	1.17	0.70	0.23	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	13.17	7.63	3.24	3.70	3.00	0.92	0.23	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	6.16	5.20	2.88	2.19	2.05	0.96	0.41	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	12.71	6.20	2.72	2.72	2.27	1.21	0.30	0.30	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	12.90	8.06	2.87	4.30	1.79	0.18	1.08	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	8.03	6.31	3.59	1.86	1.00	0.57	0.72	0.29	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	13.31	5.58	3.65	2.68	2.04	0.75	0.64	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	12.61	4.65	5.09	3.54	1.11	0.66	1.11	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	5.16	4.78	2.68	1.53	1.34	0.57	0.57	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	12.20	5.96	2.79	2.14	2.14	0.84	0.84	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	12.97	6.01	3.76	1.69	2.07	2.07	0.75	0.38	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	6.50	3.85	1.59	2.52	1.46	1.19	0.27	0.53	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	10.42	5.74	3.31	2.04	2.63	0.97	0.49	0.49	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	12.99	8.02	3.25	3.63	2.48	1.15	0.38	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	6.19	7.48	2.46	2.56	1.60	0.96	0.53	0.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	9.81	7.01	1.68	2.52	1.96	1.12	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	10.42	7.69	3.59	1.88	1.71	1.03	1.03	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	4.92	5.65	2.01	0.91	1.09	0.73	0.18	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	11.40	8.09	3.19	2.08	2.58	0.49	0.86	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	11.69	8.06	2.82	2.96	2.15	1.07	0.67	0.67	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	7.08	7.31	3.30	2.83	1.89	1.89	0.71	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	10.32	8.13	2.98	3.17	2.38	0.79	0.99	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	12.86	7.95	2.34	2.81	1.87	0.70	0.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	5.81	7.46	2.90	1.87	0.83	0.83	0.62	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	9.51	7.52	2.88	1.33	1.99	0.88	0.22	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	8.77	6.06	1.67	1.67	1.46	0.21	0.63	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	7.27	8.61	2.96	2.42	1.62	1.48	0.54	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	6.64	8.00	2.72	1.19	2.90	0.68	0.00	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	9.45	5.59	3.47	2.89	2.31	1.54	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	8.25	6.88	3.27	2.41	1.72	1.55	0.86	0.69	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	7.54	5.76	1.78	2.47	1.78	0.41	0.27	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	10.01	6.07	2.79	3.28	1.64	1.48	0.66	0.00	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	8.18	4.60	4.09	1.19	1.36	1.19	0.51	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	12.58	5.62	2.81	3.11	2.81	1.04	0.89	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	11.46	6.13	3.20	2.40	1.87	0.80	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	5.25	4.29	1.38	1.52	0.69	0.97	0.00	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	14.29	7.62	5.48	2.38	1.43	1.43	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	13.30	7.05	4.03	4.03	2.62	1.41	0.20	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	6.40	8.85	2.17	2.17	1.41	1.22	0.19	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	9.08	8.38	3.14	1.05	0.70	1.40	1.05	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	7.25	4.84	1.21	1.51	1.81	0.60	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	7.34	8.32	3.43	3.67	1.47	0.61	0.61	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	8.01	5.68	0.58	1.60	1.31	0.44	0.58	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	13.39	7.91	3.04	2.43	1.22	0.00	0.61	2.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	6.93	7.53	2.71	4.22	2.11	1.21	0.00	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	11.08	7.69	3.17	3.62	0.68	1.36	0.00	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	18.27	8.99	2.40	2.10	1.50	0.90	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	6.85	7.79	1.77	1.53	1.18	0.83	0.00	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	12.17	10.03	1.71	3.63	0.85	0.64	0.43	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	10.22	10.82	1.80	1.20	0.60	0.00	0.60	0.60	0.00
Schwann Cells, donor1	11498-119F4	26.33	12.79	12.60	9.03	9.78	3.57	2.07	1.50	0.38
Schwann Cells, donor2	11578-120F3	23.82	0.00	3.40	0.00	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	34.18	5.04	10.95	8.54	5.92	1.53	1.10	0.22	0.22
Sebocyte, donor1	11220-116B5	27.39	8.76	7.12	8.22	7.67	1.64	0.55	0.00	1.64
Sebocyte, donor2	11301-117B5	22.52	9.65	4.60	2.76	5.06	1.84	0.92	0.46	0.00
Sebocyte, donor3	11378-118B1	15.05	8.66	4.74	4.12	4.33	2.89	0.82	0.62	0.21
Sertoli Cells, donor1	11255-116F4	19.88	8.28	8.28	1.66	8.28	0.00	1.66	3.31	1.66
Sertoli Cells, donor2	11333-117F1	14.12	2.82	0.00	11.30	8.47	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	12.49	8.18	5.37	4.05	4.31	3.70	0.44	0.79	0.18
Skeletal Muscle Cells, donor2	11358-117H8	52.04	36.14	18.79	27.47	14.46	2.17	5.06	0.72	4.34
Skeletal Muscle Cells, donor3	11430-118G8	20.06	11.70	10.87	5.02	8.36	0.00	2.51	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	9.58	5.18	5.34	2.20	2.83	1.73	0.94	0.47	0.16
Skeletal Muscle Cells, donor5	11455-119A6	10.11	4.16	6.54	4.31	2.82	1.64	0.74	1.34	0.00
Skeletal Muscle Cells, donor6	11459-119B1	12.47	4.00	5.69	3.69	3.08	0.46	0.92	0.31	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	7.18	5.04	5.04	5.17	2.77	1.39	1.13	0.50	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	11.56	6.14	4.28	3.00	2.85	1.14	0.57	0.57	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	18.06	6.65	4.86	4.27	4.46	0.79	0.99	0.40	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	12.89	8.26	5.39	4.21	2.11	2.61	0.67	0.59	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	6.51	9.41	4.34	5.07	2.17	0.72	0.72	2.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.63	4.40	5.92	5.92	4.27	1.51	1.38	0.69	0.83
Skin - palm, donor1	10286-104F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	27.82	8.51	4.32	3.75	2.45	0.86	1.15	0.86	1.30
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	7.36	7.36	0.82	0.82	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	30.90	9.61	5.84	5.58	4.67	1.56	1.04	0.78	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	44.48	23.63	11.68	11.82	5.56	1.11	2.09	0.56	1.81
Small Airway Epithelial Cells, donor2	11334-117F2	34.32	13.36	6.47	5.06	4.64	1.41	2.25	0.28	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	8.46	8.03	2.96	0.85	1.06	0.42	1.27	0.21	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	85.52	26.38	17.99	12.44	11.84	1.65	2.55	0.90	1.87
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	15.43	12.34	12.65	5.25	3.39	5.55	1.23	1.85	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	2.89	3.33	2.00	1.56	0.89	0.67	0.00	0.67	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	19.99	6.47	11.17	7.05	3.53	0.59	5.88	1.18	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	13.48	7.29	6.19	4.86	6.41	1.55	0.66	0.00	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.48	10.24	9.45	7.48	3.54	2.76	2.36	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	17.77	12.36	7.73	6.18	6.18	0.77	0.00	1.55	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	6.00	4.00	2.00	4.00	1.00	1.00	0.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	23.42	8.65	14.90	8.38	7.32	1.60	2.53	0.53	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	12.86	8.87	8.42	4.65	2.66	1.55	0.44	0.89	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	3.97	4.23	1.92	1.66	1.02	0.26	1.15	0.26	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	11.72	7.49	7.49	4.56	5.86	0.98	1.30	0.65	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	13.88	4.73	7.68	3.54	2.66	1.18	1.18	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	7.97	5.13	4.70	1.71	3.13	0.43	0.57	0.28	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	14.15	9.76	8.95	5.53	4.07	1.30	0.81	0.81	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	5.78	2.44	0.61	2.13	1.83	1.52	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	19.19	11.11	9.34	7.83	7.32	2.78	1.77	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	6.12	18.36	6.12	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	21.46	12.40	7.63	6.68	10.49	0.95	0.95	1.91	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	8.11	3.69	4.13	1.18	1.77	0.74	0.15	0.44	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.78	7.10	4.74	4.30	2.80	1.08	0.43	0.43	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	12.18	5.46	5.25	3.78	4.41	1.89	0.73	0.10	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	19.18	8.20	11.29	7.89	6.50	1.70	1.86	0.62	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	18.32	10.78	8.62	9.70	2.16	2.16	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	13.45	5.68	4.48	5.08	4.48	1.20	1.49	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	21.17	5.80	12.97	7.17	9.22	2.05	2.39	1.71	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	10.21	3.38	4.79	2.83	2.98	1.26	0.39	0.47	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	16.40	9.86	5.13	4.23	3.62	2.52	2.42	0.91	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	14.11	3.41	4.78	2.05	3.41	0.23	0.23	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.68	6.64	10.26	6.04	4.83	1.81	1.81	1.81	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	21.99	7.15	4.24	5.56	4.24	2.91	1.59	0.53	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	5.73	5.06	4.66	2.13	2.00	1.33	0.53	0.00	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	8.51	5.26	4.26	3.38	2.50	1.00	0.75	0.25	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	4.57	4.82	1.78	1.78	0.51	1.78	0.25	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	18.24	8.44	10.55	7.24	5.58	1.66	1.36	0.60	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.75	9.75	8.25	6.00	3.00	0.75	0.75	0.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	14.21	10.34	19.38	9.05	25.84	1.29	0.00	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	28.83	10.70	15.35	17.21	7.91	3.72	5.12	0.47	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	20.20	10.60	10.60	7.07	7.57	2.02	4.04	1.51	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	9.72	7.52	7.21	4.39	2.19	2.19	1.88	1.25	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.19	4.42	4.42	2.06	2.06	1.18	0.59	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	8.75	4.58	4.33	1.50	3.67	1.67	0.67	0.17	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.54	1.87	2.34	3.27	0.93	1.87	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	20.58	6.48	10.07	7.63	5.32	1.01	2.88	0.58	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	34.16	8.41	13.00	5.61	8.92	3.06	1.02	1.02	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	17.68	7.33	9.03	6.21	8.09	2.82	1.13	0.75	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	15.09	3.91	6.29	3.63	4.19	1.82	0.56	0.70	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	14.33	4.11	8.63	5.45	5.19	1.84	0.67	0.34	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	37.14	2.86	9.52	6.67	2.38	4.76	0.95	1.43	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	19.33	10.03	8.56	4.65	9.05	1.96	3.67	0.49	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	5.30	7.51	6.63	4.42	4.86	0.66	0.44	0.00	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.38	10.53	7.61	4.39	5.56	2.05	1.46	0.88	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	2.14	3.89	1.94	1.17	0.39	1.55	0.19	1.36	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	5.29	5.29	2.12	0.79	1.85	0.53	0.00	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	3.35	1.86	1.49	1.49	0.74	0.00	0.00	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	5.75	2.52	4.67	2.16	2.16	2.16	0.72	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	5.68	3.41	3.69	1.14	2.56	0.57	0.85	0.57	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	8.27	1.58	3.54	2.36	1.18	1.58	1.18	0.00	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	5.08	2.54	2.79	0.51	0.76	0.51	0.00	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	3.99	2.00	2.40	0.80	1.20	0.40	0.80	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	6.69	2.51	3.76	0.00	2.09	1.67	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	3.67	3.67	2.75	0.46	1.38	1.83	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	10.10	6.73	4.04	2.19	2.36	1.18	1.18	0.50	0.34
Synoviocyte, donor2	11368-117I9	9.55	7.38	3.35	3.02	3.02	2.01	1.51	0.50	0.50
Synoviocyte, donor3	11440-118H9	5.14	3.80	1.79	0.89	0.67	0.89	0.00	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	26.44	9.29	9.29	8.58	5.72	2.14	2.86	0.36	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	3.96	1.98	0.00	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	21.53	9.72	11.58	7.41	7.64	2.78	0.69	1.39	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	18.35	12.54	7.81	8.03	5.95	0.79	1.79	0.36	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	29.77	9.28	11.60	8.50	6.57	0.77	1.93	0.00	2.71
Tracheal Epithelial Cells, donor3	11441-118I1	18.90	11.45	13.74	8.02	8.59	0.00	2.86	1.15	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	55.85	18.82	8.61	10.70	8.24	2.46	1.48	0.62	1.11
Urethra, donor2	10319-105A4	16.19	7.19	3.60	1.80	1.80	1.80	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	18.60	7.70	7.17	6.64	4.25	1.59	1.06	1.33	0.80
Urothelial Cells, donor2	11600-120H7	20.43	8.41	8.41	2.00	3.20	1.20	1.20	0.40	0.80
Urothelial Cells, donor3	11681-122H7	28.65	6.65	12.15	5.27	7.33	0.92	0.92	0.92	0.92
Urothelial cells, donor0	11216-116B1	30.09	8.25	11.37	7.13	8.47	1.56	1.56	1.11	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	25.80	10.68	6.23	8.01	0.89	5.34	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	20.01	11.44	4.29	4.29	4.29	14.30	0.00	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	21.90	12.32	2.74	6.16	1.37	2.05	0.68	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	29.27	13.77	4.13	6.20	1.72	7.23	0.00	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	34.86	14.53	4.65	4.65	4.07	3.49	0.58	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	21.87	15.62	6.25	4.16	5.21	9.37	0.00	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	15.60	12.85	11.01	1.84	2.75	11.01	1.84	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	34.69	12.78	1.83	7.30	3.65	5.48	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	32.07	10.61	3.82	6.29	5.18	1.36	2.22	0.62	0.62
Wilms' tumor cell line:HFWT	10597-108E3	12.32	5.28	1.76	0.88	2.64	0.00	1.76	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	53.63	15.36	10.89	14.52	12.57	2.51	5.03	2.51	1.12
achilles tendon, donor2	10292-104G4	6.20	8.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	63.74	8.92	9.69	8.41	3.82	4.08	1.27	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	30.65	11.61	6.27	3.71	3.25	2.79	0.00	0.46	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	58.40	16.03	5.34	2.49	2.73	8.43	0.00	1.42	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	91.16	24.49	2.99	5.44	1.63	7.35	0.82	1.36	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	24.45	10.40	5.06	3.94	1.69	1.69	0.00	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	53.29	21.99	8.67	7.61	4.86	6.56	0.42	1.06	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	131.75	19.05	11.16	27.77	5.72	3.27	1.63	0.00	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	24.68	4.85	1.76	1.76	2.20	3.97	0.00	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	33.08	16.74	2.86	4.08	1.23	6.13	0.00	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	39.61	15.53	3.11	1.16	2.72	6.21	0.00	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	36.25	10.86	4.78	4.23	4.23	5.70	0.74	1.29	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	11.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	29.28	9.30	7.20	5.34	3.72	4.65	0.00	1.63	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	17.35	13.20	6.21	3.37	3.11	8.03	0.00	4.14	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	29.22	19.58	7.60	7.60	2.92	9.64	0.00	2.92	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	26.03	18.13	6.97	4.18	2.79	5.11	0.00	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	47.71	13.98	7.81	8.64	1.65	7.81	0.00	3.70	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	19.34	9.21	1.84	0.92	1.23	0.92	0.00	0.61	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	26.46	13.65	6.40	7.25	1.28	2.99	0.43	0.43	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	21.23	16.07	4.85	3.64	2.43	3.34	0.91	1.52	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	35.62	17.81	6.98	5.30	2.41	3.13	0.48	1.93	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	21.61	8.91	2.00	4.45	2.90	2.90	0.00	0.89	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	15.34	5.34	3.00	1.33	1.67	3.67	0.33	2.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	14.87	18.58	0.00	5.57	0.00	1.86	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	42.56	13.94	3.77	4.90	4.52	4.14	0.00	0.38	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	20.50	6.11	4.36	3.05	1.31	5.67	0.00	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	39.36	7.50	1.87	1.87	1.87	1.87	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	27.79	8.95	8.71	6.59	5.18	0.24	3.53	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	15.05	12.56	3.10	3.41	2.95	3.57	0.16	0.62	0.16
adipose, donor1	10184-103D4	10.56	4.69	1.17	1.17	1.17	0.00	0.00	0.00	0.00
adipose, donor2	10185-103D5	16.63	1.62	2.43	2.84	0.81	5.27	0.41	0.00	0.00
adipose, donor3	10186-103D6	38.94	4.36	5.17	3.27	0.27	3.00	0.54	1.09	0.00
adipose, donor4	10187-103D7	23.40	4.33	1.73	0.00	6.07	0.00	0.00	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	44.35	7.42	10.42	7.10	8.05	0.79	9.63	0.63	1.10
adrenal gland, adult, pool1	10081-102A9	36.38	3.64	3.64	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	43.49	12.54	4.54	1.87	2.93	2.00	0.67	0.40	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	24.65	7.86	10.36	11.08	5.36	3.22	1.43	1.79	0.36
amniotic membrane cells, donor1	12235-129G3	20.87	10.67	3.94	4.64	3.01	2.32	0.70	0.46	0.70
amniotic membrane cells, donor2	12236-129G4	20.96	12.17	4.40	4.73	3.72	1.69	0.00	0.68	1.01
amniotic membrane cells, donor3	12237-129G5	11.49	3.24	2.06	2.36	2.06	1.47	0.88	1.47	0.88
amygdala - adult, donor10196	10167-103B5	5.93	5.93	1.19	0.00	1.19	1.19	0.00	3.56	0.00
amygdala, adult, donor10252	10151-102I7	37.92	18.86	4.26	3.45	3.65	1.82	0.41	0.61	0.41
amygdala, newborn, donor10223	10360-105E9	19.69	4.52	1.61	2.90	0.97	0.65	1.29	0.00	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	31.71	3.06	3.82	2.42	1.78	2.16	0.89	0.51	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	22.94	5.52	0.88	4.19	2.21	2.21	0.66	0.88	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	18.71	4.01	5.01	2.67	1.67	1.34	0.33	0.00	0.33
aorta, adult, pool1	10052-101G7	33.93	7.65	7.85	8.24	5.69	2.16	1.77	0.59	0.78
appendix, adult	10189-103D9	53.95	15.91	3.10	6.99	3.10	3.49	2.33	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	8.94	3.78	4.82	2.41	2.41	0.34	0.34	0.69	0.00
artery, adult	10190-103E1	14.95	8.15	1.36	1.36	0.00	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	34.62	10.29	4.93	6.95	4.78	2.75	0.43	0.29	0.72
b cell line:RPMI1788	10427-106D4	38.81	6.99	10.56	6.25	6.39	3.42	0.30	0.89	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	20.53	8.05	6.10	4.72	3.33	0.83	1.39	0.00	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	50.71	17.76	11.81	6.25	7.24	2.68	2.18	0.60	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	36.82	7.70	1.17	1.84	1.00	1.00	0.00	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	35.79	18.45	10.07	2.80	3.36	10.07	0.00	3.36	0.56
bladder, adult, pool1	10011-101C2	28.14	8.15	9.67	6.63	6.19	2.93	0.98	1.20	0.11
blood, adult, pool1	10053-101G8	26.58	13.29	2.21	2.21	2.21	11.07	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	5.99	4.28	2.57	2.57	0.86	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	12.15	13.50	4.05	4.05	2.70	0.67	0.00	0.67	0.00
brain, adult, donor1	10084-102B3	17.43	14.35	8.20	5.13	3.08	2.05	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	12.14	14.14	3.56	2.34	2.12	1.34	0.22	0.56	0.22
brain, fetal, pool1	10085-102B4	13.36	29.39	8.01	8.01	2.67	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	34.36	9.25	9.58	2.97	5.29	2.97	1.65	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	79.14	25.84	10.61	26.96	9.74	2.00	6.62	0.50	4.37
breast, adult, donor1	10080-102A8	43.56	11.36	5.68	7.58	4.42	3.79	0.00	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	30.62	8.64	11.05	11.18	8.89	0.76	4.07	0.51	2.92
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	34.32	3.40	6.18	5.26	5.26	0.31	7.73	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	17.73	7.14	13.35	5.76	5.53	1.15	11.51	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	31.47	12.10	3.39	5.08	4.84	0.48	6.29	0.48	0.97
carcinoid cell line:NCI-H1770	10703-109H1	15.52	7.52	5.64	2.35	3.29	1.88	0.94	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	136.40	21.88	16.74	37.19	13.78	2.08	11.48	0.44	5.14
carcinoid cell line:SK-PN-DW	10719-109I8	4.44	1.27	0.95	0.63	0.00	0.32	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	33.01	19.70	9.05	9.05	4.53	5.06	1.86	0.80	0.53
caudate nucleus - adult, donor10196	10177-103C6	8.06	9.21	2.30	1.15	2.30	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	49.36	25.94	5.86	5.69	5.69	4.18	0.17	1.00	0.84
caudate nucleus, adult, donor10258	10379-105H1	15.28	21.40	0.76	2.29	0.76	3.06	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	27.83	10.25	2.20	3.30	0.73	1.83	1.10	1.10	1.10
cerebellum - adult, donor10196	10173-103C2	32.05	23.31	2.91	0.00	2.91	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	48.89	23.91	5.12	5.34	4.91	3.20	1.07	0.43	0.00
cerebellum, adult, pool1	10083-102B2	17.25	12.42	3.79	4.14	3.79	2.76	0.69	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	18.27	18.27	2.49	2.49	3.32	1.66	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	21.94	13.11	3.53	4.54	1.26	2.02	1.51	1.26	0.25
cerebrospinal fluid, donor2	10294-104G6	5.85	5.85	1.46	2.19	0.73	1.46	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	41.55	14.52	4.46	4.46	1.73	8.20	0.14	1.29	0.29
cervical cancer cell line:ME-180	10553-107I4	39.77	14.42	1.82	3.81	2.49	0.66	0.50	0.33	0.83
cervix, adult, pool1	10013-101C4	19.21	11.34	4.41	4.62	3.25	3.15	1.36	0.73	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	26.75	13.93	2.93	4.46	2.93	1.95	0.98	1.11	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	2.61	0.00	1.31	1.31	1.31	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	29.08	8.95	5.34	2.11	3.11	1.37	0.62	0.50	0.37
choriocarcinoma cell line:SCH	10785-110H2	26.24	6.65	4.07	2.46	3.70	0.99	1.48	0.12	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	22.77	7.35	4.74	0.47	0.24	1.66	0.95	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	39.32	11.97	2.85	3.13	2.28	1.99	0.85	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	15.71	8.25	4.08	5.27	5.67	0.99	0.89	0.10	0.50
chorionic membrane cells, donor3	12240-129G8	28.02	7.14	1.65	1.65	3.30	2.20	1.65	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	74.73	27.26	5.05	3.03	1.01	6.06	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	22.28	4.42	3.84	3.65	2.11	2.69	0.00	0.96	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	19.43	5.91	2.75	2.75	2.75	4.65	0.42	0.42	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	21.83	8.22	4.37	4.11	0.26	6.68	0.77	2.82	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	17.42	8.71	4.11	2.42	0.97	7.01	0.73	3.39	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	18.12	10.18	2.44	2.65	1.63	6.52	0.61	2.04	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	8.54	10.89	3.53	2.06	1.18	2.65	0.59	1.77	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	29.97	11.47	6.52	5.99	3.91	5.73	0.26	0.52	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	126.63	10.97	14.17	16.92	8.46	1.60	32.00	0.46	2.29
clear cell carcinoma cell line:TEN	10636-108I6	93.52	9.37	6.42	10.58	3.12	2.08	2.43	0.35	1.04
colon carcinoma cell line:CACO-2	10513-107D9	56.93	12.81	9.70	10.07	4.58	2.75	0.73	0.00	0.37
colon carcinoma cell line:COLO-320	10420-106C6	29.27	4.94	7.98	6.08	4.94	3.80	0.76	0.00	0.00
colon, adult, donor1	10082-102B1	36.89	11.90	1.19	23.80	10.71	5.95	1.19	0.00	1.19
colon, adult, pool1	10014-101C5	24.79	19.74	5.52	9.40	4.94	2.94	1.29	0.47	1.18
colon, fetal, donor1	10070-101I7	22.25	8.03	4.94	1.85	3.09	2.47	0.62	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	9.17	13.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	62.89	25.92	10.62	15.30	6.37	1.70	10.20	0.00	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	71.39	18.87	19.62	24.15	7.70	0.30	10.11	0.45	1.96
cord blood derived cell line:COBL-a untreated	10449-106F8	64.16	17.63	15.93	20.16	9.73	0.99	16.08	0.28	1.13
corpus callosum, adult, pool1	10042-101F6	32.73	19.79	6.74	5.20	3.65	4.42	0.00	0.55	0.22
cruciate ligament, donor2	10295-104G7	8.92	4.05	2.43	1.62	1.62	0.81	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	12.04	7.22	0.80	1.61	0.80	1.61	0.00	0.00	0.00
diencephalon, adult	10193-103E4	18.00	11.76	4.08	3.12	1.68	2.16	0.00	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	52.12	5.28	3.90	3.21	3.21	3.44	1.38	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	50.01	10.51	10.00	11.28	4.36	1.28	2.31	0.77	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	15.17	3.37	0.48	5.30	2.65	1.69	1.69	0.24	1.20
ductus deferens, adult	10196-103E7	71.76	24.92	10.47	14.95	4.49	2.49	2.99	1.50	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	30.24	4.32	2.88	4.32	0.00	1.44	0.00	1.44	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	26.48	19.13	6.62	3.68	0.74	2.94	0.00	1.47	0.00
dura mater, adult, donor1	10041-101F5	6.44	6.03	3.22	2.73	2.06	1.24	0.41	0.58	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	38.20	25.98	2.00	2.44	0.89	1.55	0.89	1.33	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	16.91	8.88	4.01	3.01	3.30	3.87	0.29	0.72	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	6.78	2.47	1.85	0.62	1.23	0.62	0.00	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	7.57	1.51	1.51	1.21	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	7.72	1.54	1.54	1.54	0.31	1.54	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	11.82	2.63	0.00	0.00	1.31	0.00	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	14.41	3.02	1.34	2.01	2.35	2.01	0.67	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	51.47	16.49	8.16	7.25	4.53	1.99	5.44	0.36	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	39.56	8.52	4.50	2.57	2.41	1.45	2.41	0.32	0.32
epidermoid carcinoma cell line:A431	10426-106D3	48.02	9.23	4.56	13.01	6.11	0.56	4.11	0.33	2.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	55.32	15.95	5.50	6.71	4.95	3.96	0.11	1.54	0.66
epididymis, adult	10197-103E8	59.44	23.02	8.16	12.98	3.56	2.93	5.44	1.05	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	26.79	14.55	10.29	5.85	6.74	2.66	1.95	0.71	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	65.67	23.99	10.22	7.86	6.69	0.00	8.65	0.00	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	44.82	14.81	4.06	8.91	6.68	2.36	1.44	0.26	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	34.55	20.77	5.02	5.22	4.04	1.18	0.89	0.20	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	43.47	14.23	5.04	7.06	6.50	3.25	1.12	0.78	0.56
esophagus, adult, pool1	10015-101C6	27.92	12.00	7.54	4.57	4.57	4.35	2.02	0.53	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	29.68	14.40	7.14	6.01	3.01	1.25	6.64	0.25	0.50
eye - muscle inferior rectus, donor1	10272-104E2	2.41	21.73	2.41	0.00	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	8.42	2.10	0.00	2.10	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	5.95	4.46	0.00	0.00	0.00	0.00	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	11.46	4.59	0.00	1.15	3.44	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	14.57	4.37	1.46	1.46	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	24.15	10.68	1.78	1.27	2.80	3.81	0.00	0.76	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	7.31	3.46	2.44	1.15	1.80	1.92	0.26	0.38	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	27.78	10.45	5.70	2.85	3.09	4.99	0.47	2.37	0.00
frontal lobe, adult, pool1	10040-101F4	9.85	12.10	3.57	2.35	2.25	0.75	0.56	0.56	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	54.65	16.51	5.70	13.81	3.60	1.50	6.00	0.30	2.70
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	50.20	13.44	13.62	8.78	5.85	4.39	0.73	1.83	0.73
gall bladder, adult	10198-103E9	23.90	15.69	9.17	10.86	6.52	2.41	2.41	1.21	1.21
gamma delta positive T cells, donor1	11937-126A2	84.29	32.75	12.88	19.86	12.35	10.74	1.07	1.07	0.54
gamma delta positive T cells, donor2	11938-126A3	64.24	36.23	9.34	18.67	8.96	9.71	0.75	0.37	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	17.11	13.31	1.90	2.96	1.48	1.06	0.00	1.06	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	139.45	27.66	31.53	31.33	23.98	2.90	4.64	1.74	3.87
gastric cancer cell line:AZ521	10549-107H9	23.94	12.62	7.38	7.54	4.59	1.31	0.82	1.64	0.66
gastric cancer cell line:GSS	10560-108A2	33.86	5.49	4.58	2.75	1.83	2.75	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	53.69	10.05	8.00	13.02	4.34	2.06	0.69	0.91	0.91
giant cell carcinoma cell line:LU65	10487-107B1	9.18	9.98	1.03	1.61	0.34	3.10	0.23	1.49	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	14.14	3.22	6.30	1.54	1.96	1.54	1.40	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	72.83	16.96	5.99	8.98	3.99	2.49	3.49	0.50	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	26.28	14.46	7.18	7.07	4.22	2.32	1.37	2.43	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	30.19	13.34	7.44	3.93	4.07	5.20	0.84	1.83	0.28
glioblastoma cell line:T98G	10485-107A8	19.54	8.83	6.95	8.50	4.86	2.10	1.77	0.66	0.33
glioma cell line:GI-1	10413-106B8	103.97	19.33	19.62	31.92	14.64	2.64	4.39	0.59	1.46
globus pallidus - adult, donor10196	10175-103C4	16.76	7.29	2.92	2.92	0.73	1.46	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	81.53	35.88	9.28	8.30	8.06	3.17	0.49	0.73	0.24
globus pallidus, adult, donor10258	10367-105F7	19.17	9.58	2.74	0.00	2.74	2.74	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	42.63	11.72	1.07	4.26	2.66	0.53	1.07	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	29.37	51.39	4.89	4.89	2.45	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	32.79	0.00	0.00	10.93	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	83.63	15.68	10.45	5.23	5.23	5.23	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	12.16	5.44	4.16	5.12	2.56	1.60	0.64	0.96	0.32
hIPS +CCl2, biol_rep1	14383-156B9	14.23	4.13	5.05	4.59	1.84	1.38	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	14.18	3.20	1.83	4.57	4.57	1.83	0.00	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	14.17	3.86	5.15	2.58	2.58	1.93	0.64	0.00	0.64
hIPS, biol_rep1	14380-156B6	8.62	2.87	2.87	1.44	0.00	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	12.35	2.74	5.49	4.12	0.00	1.37	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	14.35	9.93	2.21	2.21	0.00	1.10	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	27.30	6.61	5.75	5.46	3.45	0.57	4.31	0.57	0.29
heart - mitral valve, adult	10205-103F7	23.92	15.85	2.99	4.19	1.20	2.39	0.30	1.49	0.00
heart - pulmonic valve, adult	10206-103F8	21.70	12.29	4.97	3.14	2.35	3.66	0.52	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	109.08	23.31	5.83	4.16	3.33	0.83	0.00	2.50	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	64.28	11.22	12.86	10.00	10.00	3.26	2.24	1.02	2.24
heart, adult, diseased, donor1	10051-101G6	81.33	19.59	8.09	14.05	5.54	4.68	2.13	0.43	2.55
heart, adult, pool1	10016-101C7	61.86	18.86	8.74	10.58	4.60	1.61	1.15	0.23	0.92
heart, fetal, pool1	10046-101G1	86.87	19.00	6.57	13.35	7.08	2.26	0.41	0.10	1.54
hepatic mesenchymal tumor cell line:LI90	10778-110G4	20.98	5.86	8.33	3.39	2.47	2.16	0.31	0.93	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	39.24	11.89	7.14	0.00	0.00	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	17.68	4.86	6.63	6.19	5.30	0.77	0.33	0.22	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	18.45	7.04	5.22	6.19	5.58	0.97	0.12	0.24	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	21.42	7.17	6.06	5.96	5.15	0.61	1.41	0.30	0.10
hepatoma cell line:Li-7	10484-107A7	11.90	7.67	2.00	2.11	1.56	0.78	0.11	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	26.03	12.56	6.83	3.52	6.03	3.02	0.20	0.50	0.60
hippocampus - adult, donor10196	10169-103B7	10.41	5.68	1.89	1.89	1.89	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	46.33	20.61	6.94	5.10	3.27	5.10	0.61	0.82	0.61
hippocampus, adult, donor10258	10374-105G5	6.97	10.95	1.00	2.99	0.50	1.00	1.49	1.99	0.00
hippocampus, newborn, donor10223	10363-105F3	16.21	9.52	2.11	2.82	1.06	0.70	0.70	1.41	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	20.75	6.10	4.27	3.66	2.44	0.00	0.61	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	26.51	5.89	11.98	5.11	5.50	2.16	1.77	0.79	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	24.12	6.35	6.09	3.81	5.08	1.78	1.78	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	19.17	4.51	4.51	3.38	0.56	2.26	0.00	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	11.88	5.94	7.75	2.58	1.81	1.81	0.77	0.77	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	15.18	6.07	5.69	4.18	3.04	2.66	0.38	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	18.10	3.50	7.59	3.80	1.46	2.92	0.29	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	18.74	4.52	4.52	1.72	1.29	4.74	0.22	0.86	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	19.19	7.51	7.09	2.09	1.25	2.92	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	36.70	8.05	7.81	5.21	4.50	6.16	0.24	1.18	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	39.38	7.88	6.43	4.34	3.54	5.14	0.64	0.96	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	37.03	5.39	6.06	4.04	4.71	1.35	0.67	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	21.75	4.85	7.67	3.29	4.38	1.41	1.88	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	16.21	3.93	5.40	3.93	1.97	1.97	2.46	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	8.73	5.24	3.49	0.87	0.00	1.75	0.87	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	18.33	9.55	7.45	3.44	3.63	3.05	0.00	1.15	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	12.21	8.72	5.67	3.92	3.92	3.49	0.44	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	12.99	6.50	3.50	1.00	1.00	5.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.77	3.39	3.58	1.88	2.64	6.41	0.19	0.94	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	9.09	5.91	4.55	2.27	2.27	5.91	0.45	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.60	6.26	4.70	1.25	0.94	6.89	0.00	2.51	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	78.71	8.49	4.90	6.53	2.94	5.06	3.27	1.31	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	69.67	9.00	5.23	6.39	3.77	4.06	2.32	2.03	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	55.00	7.47	3.59	4.48	1.49	5.68	1.79	0.60	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	22.35	6.28	5.36	4.80	3.14	1.11	0.92	0.37	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	27.39	7.42	9.13	4.85	5.42	1.71	1.43	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	29.81	5.31	8.17	4.90	4.08	1.22	1.22	0.82	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	15.84	5.63	3.87	1.76	3.87	1.41	0.35	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	17.42	5.07	7.60	1.27	3.17	1.58	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	23.91	7.26	6.05	4.24	2.72	2.72	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	19.65	6.21	5.69	4.14	3.10	4.14	1.03	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	19.92	2.66	3.98	1.99	0.66	5.98	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	18.73	4.87	6.93	2.82	1.80	2.31	0.26	1.28	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	50.87	7.67	8.18	9.46	3.83	3.07	1.53	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	36.35	9.09	6.06	3.79	3.79	1.51	1.51	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	49.40	6.72	4.37	10.08	2.35	1.34	2.69	0.67	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	25.12	6.04	8.69	5.31	4.11	1.21	0.48	0.00	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	16.04	7.58	1.78	4.90	2.67	0.45	0.89	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	19.02	3.90	7.80	3.41	5.85	0.98	1.46	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	18.34	6.42	5.20	3.06	4.28	3.36	0.31	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6.51	0.00	3.25	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	18.53	4.30	2.98	1.65	1.99	0.66	0.00	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	24.08	7.11	5.47	1.09	1.64	4.93	0.00	1.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	16.65	3.98	4.70	1.45	1.81	2.90	0.00	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	12.81	3.56	4.63	2.49	1.42	2.14	0.36	1.42	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	19.09	5.97	11.93	3.58	0.00	0.00	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	47.67	8.67	7.04	6.36	4.20	2.84	2.30	0.95	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	36.37	5.93	8.08	7.27	2.96	2.96	1.62	0.81	0.27
immature langerhans cells, donor1	11904-125F5	6.05	6.05	1.45	2.91	0.97	1.45	0.00	0.24	0.24
immature langerhans cells, donor2	11905-125F6	9.51	4.75	4.75	3.96	2.38	1.58	0.00	2.38	0.00
insula, adult, pool1	10039-101F3	13.06	15.52	3.41	3.03	2.18	1.70	0.76	0.57	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	31.21	10.08	5.20	8.45	7.15	1.30	1.30	0.33	1.95
kidney, adult, pool1	10017-101C8	96.92	24.23	10.51	16.52	8.11	3.40	10.21	0.80	2.00
kidney, fetal, pool1	10045-101F9	70.88	14.93	5.09	7.07	3.47	2.41	1.70	0.92	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	4.40	1.56	3.98	1.99	1.42	0.85	0.14	0.43	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	19.77	8.02	3.87	6.36	3.18	1.38	0.97	0.28	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	75.23	12.29	5.14	2.02	3.30	3.49	0.18	1.47	0.18
left atrium, adult, donor1	10079-102A7	15.26	7.08	5.99	5.45	3.27	1.63	1.09	1.09	0.00
left ventricle, adult, donor1	10078-102A6	49.05	6.57	7.58	3.54	3.03	4.05	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	9.03	8.76	3.01	5.47	3.83	1.09	1.64	0.55	0.82
leiomyoma cell line:10964C	10569-108B2	11.50	7.18	4.31	3.23	1.80	1.80	0.00	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	4.89	2.17	3.26	1.63	2.72	1.63	0.00	1.63	0.54
leiomyoma cell line:15425	10571-108B4	9.47	6.07	5.34	2.43	2.19	1.46	1.70	1.21	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	12.70	0.00	0.00	12.70	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	30.32	8.36	4.18	3.14	2.09	0.00	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	25.97	5.55	3.66	7.32	4.37	0.94	0.83	0.24	0.83
liposarcoma cell line:KMLS-1	10782-110G8	11.40	7.03	4.37	1.41	2.66	2.03	0.16	0.47	0.00
liposarcoma cell line:SW 872	10726-110A6	24.61	11.45	5.24	7.55	5.60	0.97	0.49	0.49	0.49
liver, adult, pool1	10018-101C9	52.83	17.02	15.23	21.23	10.86	1.78	13.78	0.49	4.54
liver, fetal, pool1	10086-102B5	27.28	6.58	6.58	2.82	6.58	0.94	2.82	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	15.46	8.02	2.92	2.77	1.46	1.31	0.44	0.44	0.15
locus coeruleus, adult, donor10252	10165-103B3	64.78	21.41	5.54	5.17	6.27	3.32	0.55	0.55	1.11
locus coeruleus, adult, donor10258	10375-105G6	21.72	10.44	4.51	3.95	1.69	3.39	0.56	1.13	0.28
locus coeruleus, newborn, donor10223	10362-105F2	26.08	6.31	0.42	3.36	0.42	1.26	0.42	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	43.32	18.82	9.13	15.50	8.44	1.52	4.57	0.28	2.49
lung adenocarcinoma cell line:PC-14	10408-106B3	26.89	9.65	8.96	12.41	2.07	1.38	0.69	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	21.35	7.78	8.17	4.88	3.82	1.32	1.05	0.00	0.13
lung, adult, pool1	10019-101D1	36.27	13.58	9.10	8.27	5.20	2.60	0.71	0.59	0.35
lung, fetal, donor1	10068-101I5	27.40	13.41	7.71	4.57	1.71	4.28	0.29	0.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	44.45	20.62	10.08	4.12	8.25	2.75	0.00	0.46	0.46
lymph node, adult, donor1	10077-102A5	24.14	4.26	3.79	6.63	1.89	1.42	0.00	1.42	1.42
lymphangiectasia cell line:DS-1	10727-110A7	94.68	12.27	12.27	8.99	8.33	3.95	1.32	1.75	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	45.88	19.92	4.53	1.36	1.36	1.81	0.00	0.60	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	65.41	15.29	3.40	9.34	2.55	7.65	0.00	3.40	1.70
mature adipocyte, donor1	12231-129F8	11.10	14.21	7.55	1.33	1.33	3.55	0.44	1.33	0.44
mature adipocyte, donor2	12232-129F9	15.98	13.28	6.43	0.62	2.49	3.11	0.21	1.66	0.00
mature adipocyte, donor3	12233-129G1	9.48	9.48	4.98	3.08	2.37	3.56	0.00	1.42	0.00
mature adipocyte, donor4	12234-129G2	8.95	10.27	4.74	1.05	1.32	1.84	0.00	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	81.01	34.79	15.73	21.21	10.96	2.14	2.86	1.43	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	6.77	10.15	2.26	0.00	0.00	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	38.44	20.23	3.49	3.31	3.49	3.49	0.37	0.74	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	4.13	11.12	1.59	0.64	1.27	0.64	0.64	0.64	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	8.10	7.25	0.85	1.71	0.43	0.00	0.43	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	7.76	9.62	2.19	1.18	1.01	0.68	0.34	0.84	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	43.93	20.37	4.67	3.61	2.76	3.18	0.21	1.49	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	9.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	14.00	9.69	2.15	2.87	0.72	1.79	1.08	1.44	1.08
medulla oblongata - adult, donor10196	10174-103C3	20.77	3.24	0.65	0.00	2.60	1.95	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	50.47	21.83	6.35	6.50	4.33	3.25	0.31	1.55	0.15
medulla oblongata, adult, pool1	10038-101F2	27.83	14.28	5.14	5.47	4.08	1.63	0.41	0.57	0.82
medulla oblongata, newborn, donor10223	10361-105F1	67.70	13.54	5.90	5.21	2.78	3.12	0.35	1.74	1.04
medulloblastoma cell line:D283 Med	10838-111E1	13.73	6.86	5.54	2.21	0.89	2.21	0.22	0.66	0.22
medulloblastoma cell line:ONS-76	10759-110E3	35.83	5.62	9.78	4.40	6.36	1.47	3.67	0.37	0.61
melanoma cell line:COLO 679	10514-107E1	5.89	8.19	1.58	1.87	1.01	0.57	0.00	0.14	0.00
melanoma cell line:G-361	10465-106H6	7.60	3.53	5.43	1.36	1.63	0.81	0.81	0.81	0.00
meningioma cell line:HKBMM	10691-109F7	21.89	3.62	6.69	3.62	3.80	0.72	0.72	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	27.32	6.17	7.93	0.00	0.00	6.17	0.88	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	26.96	14.00	5.70	3.89	2.33	2.85	0.26	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	11.81	10.43	9.82	6.14	6.60	1.99	2.45	1.38	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.00	15.45	11.27	8.54	6.91	1.82	3.09	1.09	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	4.56	4.97	5.38	4.14	1.66	1.66	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4.92	4.35	4.21	1.40	1.97	0.42	1.12	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	5.01	6.93	5.97	4.04	1.93	0.77	0.77	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	7.63	2.08	2.08	2.08	0.69	2.08	1.39	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	34.84	18.88	15.96	15.28	10.30	2.23	3.95	0.34	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	5.06	6.56	3.34	2.53	2.30	1.27	0.46	0.23	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.46	9.55	9.42	5.97	4.77	1.33	1.99	0.66	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	12.69	9.72	6.08	4.73	3.92	0.81	1.49	0.68	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	15.36	8.96	11.24	6.54	7.82	1.71	3.13	0.85	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	40.51	15.48	16.14	10.87	8.23	2.31	2.96	1.32	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	15.22	6.78	9.82	5.53	6.23	1.25	1.66	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	8.38	9.08	8.38	2.79	1.75	0.35	1.40	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	10.82	7.96	10.62	4.70	2.65	1.02	1.43	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	12.58	8.63	6.11	8.27	5.39	1.08	0.72	0.00	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	10.34	8.59	7.86	4.34	4.55	1.66	1.45	0.62	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.21	4.79	2.51	3.19	1.37	1.37	0.68	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	6.29	4.20	0.84	1.26	0.84	0.00	0.84	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	6.72	5.68	3.89	3.59	4.03	0.60	1.20	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	21.88	13.39	9.72	10.15	7.53	1.49	2.63	0.26	0.61
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	27.61	13.62	12.15	7.73	8.84	2.21	1.47	1.10	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	7.15	4.29	2.58	1.72	2.29	1.14	2.29	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	13.47	8.84	2.95	4.63	2.53	2.95	0.42	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	8.68	7.76	2.74	5.02	2.28	2.28	1.83	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	6.91	7.42	3.07	4.09	3.33	1.79	0.26	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	6.81	4.97	5.76	5.50	2.36	1.83	1.83	0.79	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	5.85	7.70	3.70	5.55	4.01	2.46	1.23	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	6.59	7.30	4.24	3.06	1.65	1.88	1.41	0.94	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	7.45	8.46	5.08	3.72	2.71	2.03	0.68	1.02	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	7.86	7.86	1.96	2.75	1.18	2.75	1.57	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	6.95	6.49	1.85	1.85	1.85	1.39	1.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	11.25	7.21	8.94	3.75	3.17	2.88	0.00	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	8.25	6.92	4.02	4.24	3.57	2.45	1.12	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	9.13	5.05	2.40	3.12	3.36	1.92	0.48	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	2.20	7.33	2.93	2.20	0.73	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	8.39	5.03	2.35	4.70	2.01	2.01	1.68	1.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	9.83	4.09	2.46	4.09	3.28	0.41	0.82	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.44	5.58	3.44	2.15	1.72	0.86	2.58	0.43	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	5.47	2.73	2.73	5.47	2.73	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6.82	3.57	3.57	1.62	1.30	0.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	5.82	4.36	5.82	1.45	1.45	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.60	5.33	1.07	3.20	1.60	2.67	2.13	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.09	1.64	3.27	3.27	1.64	1.64	1.64	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.83	3.89	2.72	2.33	1.94	1.17	2.33	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	2.10	4.20	0.00	4.20	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	2.98	5.96	0.00	2.98	1.99	0.99	1.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	5.93	7.12	4.15	2.96	1.78	1.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	0.00	4.87	2.44	2.44	1.22	0.00	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5.07	7.60	4.43	3.17	0.63	0.63	1.27	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	4.48	6.21	4.14	2.07	1.72	1.38	0.69	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	2.15	6.45	4.30	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	3.99	0.00	3.99	3.99	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	6.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	7.33	3.26	3.26	4.07	1.63	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	2.38	4.77	5.56	2.38	0.79	0.79	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.31	4.72	1.77	4.13	1.77	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.68	3.12	3.74	1.56	2.18	0.62	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1.34	4.01	5.35	0.00	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	4.73	1.18	4.73	2.37	2.37	2.37	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	2.57	2.57	7.70	5.14	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	6.20	7.57	4.82	3.44	0.69	2.07	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	11.88	7.92	3.96	3.96	2.47	1.48	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	8.97	2.24	7.85	0.00	4.49	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	9.54	8.27	1.27	3.82	3.82	0.00	0.64	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	9.27	8.87	3.63	2.01	2.01	1.21	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	13.08	0.00	0.00	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	13.94	7.60	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	36.41	29.13	13.96	12.74	11.53	3.64	1.82	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	36.15	22.59	18.08	4.52	0.00	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	43.66	36.24	9.88	11.53	8.24	0.82	1.65	1.65	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	5.95	5.75	1.98	3.17	1.39	1.19	0.40	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	6.81	8.11	1.30	3.89	2.92	1.62	0.32	0.65	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	10.19	3.06	3.06	1.02	2.04	0.00	0.00	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	7.74	6.96	1.55	3.87	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	16.30	7.32	5.91	5.43	4.25	1.65	0.94	0.47	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	22.01	7.65	7.18	9.50	6.72	0.46	2.55	0.00	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	4.27	4.27	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	6.88	7.50	1.03	1.95	0.72	0.92	0.10	0.10	0.21
mesothelioma cell line:Mero-25	10850-111F4	39.04	11.80	4.09	6.58	2.95	0.68	0.68	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	18.09	7.58	6.60	4.89	2.44	0.73	0.73	0.24	0.98
mesothelioma cell line:Mero-48a	10852-111F6	28.79	12.40	5.98	4.65	3.99	2.44	1.77	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	11.56	9.46	2.37	4.99	0.79	2.10	0.53	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	14.47	7.32	3.23	2.72	1.02	1.19	0.51	0.34	0.34
mesothelioma cell line:Mero-84	10855-111F9	34.12	6.07	5.31	8.59	4.80	0.76	1.52	0.00	0.76
mesothelioma cell line:Mero-95	10856-111G1	26.92	14.70	5.80	8.49	2.48	1.66	0.62	0.83	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	65.76	19.88	13.91	10.10	5.80	4.97	1.33	1.99	0.83
mesothelioma cell line:NCI-H226	10846-111E9	19.00	7.42	5.97	7.06	5.25	1.27	0.18	0.00	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	23.06	12.13	6.32	5.30	6.32	2.22	0.51	0.17	0.34
mesothelioma cell line:NCI-H28	10845-111E8	9.42	4.58	3.56	2.04	0.51	1.27	0.76	1.53	0.25
mesothelioma cell line:No36	10857-111G2	11.09	13.37	2.28	1.96	2.61	4.89	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	19.24	7.04	5.69	2.71	1.63	0.81	0.27	0.00	0.54
migratory langerhans cells, donor1	11901-125F2	57.58	4.22	14.20	11.90	6.33	3.26	4.80	1.15	0.77
migratory langerhans cells, donor2	11902-125F3	62.40	6.84	18.07	15.39	4.40	2.56	4.15	0.12	1.10
migratory langerhans cells, donor3	11903-125F4	42.18	3.05	14.72	15.44	5.74	2.51	1.26	0.90	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	26.12	10.45	2.29	0.65	0.33	0.33	0.33	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	18.65	3.60	3.18	3.39	3.81	0.42	1.48	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	56.90	10.60	18.66	10.83	9.68	2.76	4.84	1.15	1.15
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	40.34	7.23	10.85	7.23	6.66	1.14	2.28	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	40.28	16.26	4.44	2.40	2.03	7.58	0.00	0.37	0.18
myeloma cell line:PCM6	10474-106I6	70.57	15.81	20.56	9.49	10.28	4.15	3.76	0.59	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	10.65	4.57	3.55	3.55	0.51	1.01	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	50.21	33.93	14.91	7.26	6.47	7.85	0.39	0.78	1.37
nasal epithelial cells, donor1, tech_rep1	12226-129F3	52.70	18.16	14.93	12.15	8.69	2.12	2.56	0.33	0.78
nasal epithelial cells, donor1, tech_rep2	12226-129F3	58.10	15.00	11.33	8.82	6.32	2.13	1.47	1.10	1.18
nasal epithelial cells, donor2	12227-129F4	28.70	7.73	13.25	9.38	3.86	0.55	2.21	0.00	2.21
neuroblastoma cell line:CHP-134	10508-107D4	12.19	8.28	4.83	2.07	2.07	5.75	0.00	1.61	0.00
neuroblastoma cell line:NB-1	10539-107G8	30.49	11.97	9.17	9.54	5.24	2.99	1.12	0.94	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	66.22	26.15	8.65	8.65	6.75	9.91	0.63	1.90	0.21
neuroblastoma cell line:NH-12	10555-107I6	17.14	10.99	3.73	2.80	2.80	3.73	0.19	0.56	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	3.80	2.14	1.19	0.47	0.00	1.66	0.00	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	10.77	4.59	1.43	1.11	0.16	1.58	0.00	1.43	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	26.97	8.65	7.45	4.43	7.85	4.43	0.40	1.21	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	5.72	3.18	0.00	0.64	1.27	1.27	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	19.70	4.79	5.86	3.73	4.52	0.53	1.33	1.06	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	9.47	0.00	0.00	0.00	9.47	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	37.71	6.09	7.61	5.07	4.23	3.38	0.34	1.01	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	25.62	7.20	9.61	8.01	4.80	3.20	0.00	0.00	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	13.47	7.05	1.60	2.24	3.21	0.00	0.64	0.00	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	8.15	6.83	4.73	2.10	2.10	1.31	1.05	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	14.15	13.78	3.84	2.72	2.44	1.59	0.47	0.37	0.09
occipital cortex - adult, donor10196	10172-103C1	4.12	2.06	2.06	2.06	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	54.48	22.27	6.44	6.44	4.03	2.42	0.27	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	17.11	14.19	1.09	5.10	1.46	1.82	1.46	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	10.23	18.11	3.67	3.67	1.84	1.05	0.00	1.05	0.00
occipital lobe, fetal, donor1	10073-102A1	12.01	9.01	0.86	0.00	0.86	6.44	0.43	2.57	0.00
occipital pole, adult, pool1	10036-101E9	17.11	15.53	3.39	3.07	1.97	2.44	0.39	1.42	0.16
olfactory region, adult	10195-103E6	16.05	10.32	4.20	2.10	3.44	1.34	0.00	0.76	0.00
optic nerve, donor1	10277-104E7	34.02	12.01	2.00	4.00	4.00	4.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	102.29	20.62	10.14	23.58	10.14	2.85	9.80	0.46	3.76
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	16.49	8.52	5.77	3.16	4.26	0.55	0.27	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	25.57	7.62	4.40	6.10	3.73	2.54	1.35	0.17	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	13.63	3.00	4.16	1.62	3.00	0.92	0.23	0.23	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	11.46	6.76	4.70	1.76	1.76	1.47	1.18	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	38.31	10.28	23.36	22.42	14.02	0.93	3.74	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	46.44	16.33	4.67	21.84	7.21	1.91	5.51	0.21	2.54
ovary, adult, pool1	10020-101D2	22.80	9.26	5.07	4.37	2.62	2.01	0.61	0.52	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	21.27	5.50	3.48	2.38	2.93	2.57	0.00	1.47	0.18
pancreas, adult, donor1	10049-101G4	68.67	15.99	17.87	19.75	15.05	1.88	6.58	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	29.63	2.52	3.63	0.56	1.96	0.84	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	55.88	14.48	8.86	7.33	4.43	2.73	1.19	1.53	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	74.51	9.60	5.46	4.47	2.81	2.48	1.16	0.66	0.33
paracentral gyrus, adult, pool1	10035-101E8	13.55	15.65	2.75	2.47	2.38	1.65	0.18	0.37	0.18
parietal cortex, adult, donor10258	10373-105G4	11.74	7.34	2.94	0.73	0.00	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	14.11	11.29	0.94	1.88	2.82	1.88	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	29.07	16.53	3.71	2.85	2.57	3.42	0.29	0.00	0.29
parietal lobe, adult, pool1	10034-101E7	15.07	16.30	2.82	2.03	2.20	1.94	0.26	0.35	0.26
parietal lobe, fetal, donor1	10072-101I9	4.85	7.76	2.91	2.91	0.97	3.88	0.00	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	13.83	9.72	1.12	1.50	1.12	0.75	0.37	1.50	0.75
parotid gland, adult	10199-103F1	180.68	41.32	12.95	19.73	3.08	8.02	2.47	1.23	2.47
penis, adult	10200-103F2	8.06	8.06	3.76	1.61	2.15	4.30	0.54	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	26.40	6.32	1.12	5.58	0.56	2.60	0.74	0.93	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	85.38	33.07	22.29	18.21	19.09	5.39	2.33	1.75	2.19
pineal gland - adult, donor10196	10179-103C8	6.45	6.45	0.65	0.65	0.65	1.29	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	16.58	14.21	2.37	1.78	1.18	4.15	0.00	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	13.80	12.54	1.25	0.63	0.00	1.25	0.00	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	25.30	11.13	5.06	4.05	3.04	3.04	1.01	4.05	0.00
pituitary gland, adult, donor10252	10162-103A9	27.10	15.11	2.61	4.17	2.08	4.69	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	13.62	12.77	5.11	1.70	1.70	0.85	2.55	0.85	0.00
placenta, adult, pool1	10021-101D3	35.69	19.14	6.67	3.23	3.12	2.04	0.65	0.54	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	63.04	16.82	6.49	6.49	5.43	1.32	1.19	0.66	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	207.16	41.71	33.77	34.40	23.66	16.50	9.49	3.27	3.27
pons, adult, pool1	10033-101E6	13.60	11.53	4.30	2.32	1.38	1.46	0.34	0.52	0.09
postcentral gyrus, adult, pool1	10032-101E5	11.33	17.00	3.14	2.27	1.57	1.57	0.17	0.70	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	29.28	50.19	2.09	2.09	2.09	2.09	0.00	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	77.11	27.54	11.02	11.02	0.00	16.52	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	93.89	23.47	0.00	23.47	0.00	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	22.72	10.63	7.87	3.93	5.39	0.58	1.89	0.44	0.44
prostate cancer cell line:PC-3	10439-106E7	49.19	10.89	15.06	14.34	10.53	1.27	10.35	0.54	0.54
prostate, adult, pool1	10022-101D4	27.84	13.79	6.98	4.35	4.72	4.26	0.27	0.63	0.36
putamen, adult, donor10196	10176-103C5	12.75	19.59	2.12	1.89	1.89	1.18	0.00	1.18	0.24
putamen, adult, donor10252	10152-102I8	58.82	41.18	5.88	9.80	0.00	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	9.84	3.28	2.19	2.19	0.00	1.09	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	10.39	13.53	0.97	2.17	2.17	1.45	0.00	1.45	0.00
putamen, newborn, donor10223	10365-105F5	16.49	5.25	0.75	2.25	1.50	1.50	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	125.10	20.07	2.04	15.42	2.62	1.75	1.45	0.00	1.75
rectum, fetal, donor1	10067-101I4	16.69	6.95	1.39	1.39	4.17	1.39	0.00	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	110.03	13.36	18.23	14.63	5.72	2.12	26.08	0.85	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	50.12	4.56	4.56	9.53	2.90	2.07	6.21	0.00	0.41
retina, adult, pool1	10030-101E3	16.70	14.31	3.08	2.58	1.79	2.58	0.20	0.50	0.10
retinoblastoma cell line:Y79	10475-106I7	13.77	6.75	4.68	4.42	2.60	2.08	0.26	0.26	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.55	5.16	7.75	2.21	4.18	0.37	1.35	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	12.09	4.50	5.34	0.84	0.84	1.69	0.00	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	6.06	3.79	3.03	3.03	1.52	1.52	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	10.20	4.53	5.34	5.66	2.43	0.49	2.10	0.16	0.49
salivary acinar cells, donor2	11772-123I8	8.54	5.78	2.34	3.17	1.79	1.10	1.10	0.83	0.28
salivary acinar cells, donor3	11773-123I9	9.93	6.62	3.97	1.99	1.32	0.66	0.66	0.00	0.66
salivary gland, adult, pool1	10093-102C3	34.89	12.01	14.87	6.29	3.43	8.01	2.86	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	8.60	6.32	5.06	1.10	2.45	0.84	0.00	0.34	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	6.94	6.35	4.58	2.00	2.47	0.71	0.47	0.35	0.12
seminal vesicle, adult	10201-103F3	47.62	13.23	10.05	15.34	5.82	5.82	4.76	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	63.65	19.43	2.19	11.66	1.21	3.40	1.94	1.70	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	35.73	11.32	4.78	9.06	1.76	2.77	1.26	1.01	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	54.19	20.07	10.04	15.05	5.02	5.02	6.02	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	87.71	12.89	2.42	3.90	1.75	1.34	5.10	0.40	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	58.47	18.68	9.28	9.51	6.30	3.43	2.87	0.44	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	24.39	9.16	4.64	4.64	2.06	0.77	1.94	0.39	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	9.93	3.55	0.71	0.71	0.00	2.13	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	17.63	10.19	2.16	2.64	1.44	2.88	0.12	0.24	0.36
skeletal muscle, fetal, donor1	10066-101I3	6.03	2.01	1.01	2.01	2.01	1.01	0.00	3.02	0.00
skin, adult, donor1	10074-102A2	0.00	6.79	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	7.57	3.79	2.52	1.89	1.26	1.26	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	30.68	4.34	6.67	6.34	5.34	2.33	2.33	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	18.60	7.25	3.15	2.84	2.84	1.89	1.26	0.63	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	36.81	20.05	7.90	2.70	4.05	7.32	9.44	4.05	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	7.58	4.29	4.29	2.31	3.13	0.99	0.66	0.16	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	44.39	6.27	4.18	2.09	2.57	3.06	0.16	1.45	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	68.86	18.96	12.42	11.77	7.63	2.83	0.87	0.44	0.44
small intestine, adult, pool1	10024-101D6	41.81	21.14	5.14	9.08	5.73	1.55	2.63	0.60	2.27
small intestine, fetal, donor1	10064-101I1	71.01	15.72	4.18	6.14	3.93	2.95	1.72	1.97	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	35.39	12.31	8.21	18.46	7.69	1.03	6.67	1.03	0.51
smooth muscle, adult, pool1	10048-101G3	17.83	8.01	6.72	1.29	2.58	2.58	0.52	1.03	0.26
somatostatinoma cell line:QGP-1	10781-110G7	52.00	16.62	14.21	23.85	14.21	3.22	23.32	0.54	4.02
spinal cord - adult, donor10196	10181-103D1	24.32	6.88	2.52	2.06	2.29	2.29	0.69	1.15	0.00
spinal cord, adult, donor10252	10159-103A6	32.72	15.38	3.94	5.13	2.76	0.79	0.00	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	9.69	11.76	3.46	0.00	1.38	1.38	0.00	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	25.00	12.81	7.93	3.05	2.44	1.83	0.00	1.83	0.61
spinal cord, newborn, donor10223	10359-105E8	43.63	19.75	1.84	4.13	0.92	1.38	0.46	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	12.25	8.51	6.42	3.73	3.58	0.45	1.34	0.45	0.60
spleen, adult, pool1	10025-101D7	30.29	12.89	5.51	5.40	3.63	2.64	0.77	0.66	0.22
spleen, fetal, pool1	10044-101F8	31.07	14.22	3.97	5.48	4.05	4.13	0.40	0.64	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.22	2.59	2.38	2.59	1.86	1.55	2.07	0.41	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	18.61	3.04	3.99	3.61	3.04	1.14	0.57	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	38.09	9.09	6.99	5.94	7.34	2.80	1.05	1.40	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	66.07	5.86	4.30	4.30	3.13	1.95	0.39	1.17	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	46.26	21.72	6.75	3.94	2.14	7.88	0.68	1.91	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	55.07	6.78	2.54	3.81	1.69	1.27	3.81	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	50.77	22.42	9.31	29.19	10.58	0.85	9.73	0.42	4.65
stomach, fetal, donor1	10062-101H8	9.61	7.48	1.07	4.27	1.07	0.00	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	75.20	28.48	6.84	4.56	7.41	7.98	1.14	2.28	1.71
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	62.52	25.13	5.40	7.48	3.95	2.08	0.21	0.42	0.62
substantia nigra, adult, donor10258	10371-105G2	10.86	11.38	3.10	1.55	1.03	1.55	0.52	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	43.81	13.42	4.24	4.24	2.12	2.12	0.71	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	12.84	9.17	5.04	2.06	2.75	1.38	0.23	1.15	0.00
temporal lobe, adult, pool1	10031-101E4	14.50	17.21	4.75	2.71	2.97	2.20	0.51	0.59	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	9.97	9.97	1.42	1.42	0.71	4.99	0.71	2.85	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	10.99	13.19	3.08	2.20	2.64	2.20	0.44	1.32	0.00
tenocyte, donor1	11763-123H8	10.47	11.52	7.33	4.89	3.84	1.75	2.09	0.70	0.70
tenocyte, donor2	11765-123I1	6.10	4.20	1.91	3.43	2.29	0.76	0.76	0.00	0.38
tenocyte, donor3	11768-123I4	4.08	6.30	3.71	2.97	1.11	1.48	0.37	1.48	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	36.71	5.27	12.41	3.40	4.93	1.87	1.87	0.85	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	17.26	4.62	3.85	0.77	3.24	0.77	0.00	0.15	0.31
teratocarcinoma cell line:PA-1	10807-111A6	27.43	3.56	6.82	2.17	3.10	2.48	0.31	0.77	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	39.61	10.41	8.76	3.43	6.35	2.67	1.65	0.38	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	20.04	6.81	3.03	1.89	0.38	2.27	0.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	19.74	2.29	2.18	2.07	1.42	0.65	0.76	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	20.19	3.91	3.26	0.33	0.33	0.98	0.33	0.65	0.00
testis, adult, pool1	10026-101D8	15.03	13.31	3.87	3.76	2.47	2.47	0.43	0.64	0.21
testis, adult, pool2	10096-102C6	23.46	13.08	2.26	1.35	1.80	0.90	0.45	1.80	0.45
thalamus - adult, donor10196	10168-103B6	15.46	8.83	0.00	0.00	0.00	0.00	0.00	1.10	1.10
thalamus, adult, donor10252	10154-103A1	61.26	26.88	5.94	8.28	4.22	4.06	0.31	0.78	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	23.09	15.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	17.13	11.86	2.31	2.47	2.31	2.47	0.00	0.66	0.00
thalamus, newborn, donor10223	10366-105F6	12.08	6.90	0.58	1.73	0.58	0.58	1.15	1.15	0.00
throat, adult	10209-103G2	24.22	15.48	3.25	5.49	2.50	1.50	0.25	1.00	1.50
throat, fetal, donor1	10061-101H7	31.38	10.06	2.44	1.22	0.30	2.74	0.30	0.91	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	9.34	3.58	5.56	3.38	3.18	1.99	2.98	1.39	0.40
thymus, adult, pool1	10027-101D9	61.14	30.12	3.78	4.67	2.98	11.73	0.30	4.08	0.50
thymus, fetal, pool1	10043-101F7	41.56	17.14	3.12	3.22	2.60	7.38	0.42	1.77	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	97.19	23.27	24.20	16.35	13.30	5.05	6.52	1.73	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	259.41	30.59	18.86	27.10	21.65	5.59	25.14	1.12	5.17
thyroid, adult, pool1	10028-101E1	243.83	62.33	13.25	12.60	8.49	8.68	1.49	2.24	1.68
thyroid, fetal, donor1	10060-101H6	110.74	25.31	3.95	3.16	2.90	4.48	0.53	2.37	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	6.16	0.00	3.08	0.00	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	13.02	11.86	2.09	3.26	2.79	1.16	1.40	0.70	1.16
tongue, fetal, donor1	10059-101H5	18.52	6.70	0.79	1.58	0.39	0.79	0.00	0.39	0.00
tonsil, adult, pool1	10047-101G2	53.99	17.53	6.61	8.11	5.21	4.91	2.00	0.70	1.20
trachea, adult, pool1	10029-101E2	42.21	16.93	10.39	12.19	5.97	2.13	1.88	0.41	1.15
trachea, fetal, donor1	10058-101H4	31.16	11.54	1.92	4.23	2.31	1.92	1.15	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	8.86	3.90	4.25	3.54	2.83	1.06	0.00	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	125.33	18.03	9.93	14.99	9.63	2.03	3.55	0.71	1.62
transitional-cell carcinoma cell line:JMSU1	10492-107B6	26.32	11.59	7.68	21.00	5.95	1.41	3.92	0.16	1.25
tridermal teratoma cell line:HGRT	10694-109G1	1.90	0.00	1.90	1.90	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	32.17	14.64	8.47	15.49	8.63	1.10	1.86	0.25	1.95
umbilical cord, fetal, donor1	10057-101H3	35.47	6.26	4.17	8.35	2.09	8.35	4.17	2.09	0.00
uterus, adult, pool1	10100-102D1	14.33	11.09	5.29	2.39	0.85	4.61	0.51	1.37	0.17
uterus, fetal, donor1	10055-101H1	15.36	4.61	2.56	1.02	3.07	0.00	1.02	1.54	0.00
vagina, adult	10204-103F6	78.19	18.09	11.63	2.58	6.46	5.17	0.00	0.00	0.65
vein, adult	10191-103E2	30.03	15.56	3.29	5.48	1.97	2.41	0.00	2.41	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	18.43	6.41	3.74	3.74	1.87	0.53	1.34	0.27	0.00